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MICROENVIRONMENTAL CONTROL OF EPITHELIAL CELL FATE 
SETH EMERSON WAKEFIELD 
ABSTRACT 
Cancer is a devastating condition, yet its prevalence is not surprising when one 
considers the possibility that growth and motility define the default state of epithelial 
cells. What is more surprising is that epithelial cells can be induced to a “fragile 
quiescent state” in multicellular organisms through constant inhibitory influences from 
extracellular sources. In other words, the immotile and growth-constrained behavior we 
associate with epithelia (quiescence) is not the default state cells in a multicellular 
organism, but rather must be exogenously induced by tissue-specific (and systemic) 
factors. Quiescence therefore, is a fragile existence for any cell, as the removal of 
differentiating signals should cause the cell to revert to a migratory, stem-like default 
state. It will be argued that cancer is better understood as a disease of tissues rather 
than individual cells, and the complexities of tissues cannot be inferred from the study 
of cells in isolation. In-vitro studies which have been used to explain carcinogenesis will 
be critically reviewed and their relevance to in-vivo conditions will be questioned. 
Complex signaling mechanisms define the relationship between the epithelium and 
other cells in a metazoan tissue. These signals originate both from the 
stromal/mesenchymal compartments and between epithelial cells. Studies have shown 
that carcinogenic insults which affect the stroma alone can turn an otherwise normal 
epithelium cancerous, while transplanting “cancerous” epithelial cells into an otherwise 
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normal stroma does not result in neoplasm formation. Experimental evidence has 
confirmed that the differentiation fate of any epithelial cell is malleable depending on 
its environmental context. Further, it was previously thought that epithelium had to 
dramatically change identity in order to be capable of migration. It will be shown that 
collective motility is an endogenous capability of epithelial cells, and multiple non-
mammalian and mammalian in-vivo studies of collective epithelial motility will be 
reviewed to better understand epithelial motility in cancer. In fact, it will be shown that 
the creation of adhered epithelial sheets requires the same morphological changes 
necessary for motility. Lastly, evidence that heterogeneous cell populations contribute 
to epithelial cell migration in development and metastasis will be presented.  
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INTRODUCTION: Assumptions of the Somatic Mutation Theory  
 
According to the National Cancer Institute (NCI), there will be 1.68 million newly 
diagnosed cases of cancer during 2016 in the United States. Nearly 600,000 people will 
die of cancer this year, making it the second leading cause of death (“Cancer Statistics - 
National Cancer Institute” 2016). In 2013 expenditures in the United States for cancer 
treatment totaled nearly $125 billon, and this number is predicted to rise by nearly 25% 
over the next 4-5 years. As a sign of hope for research efforts to date, nearly 14.5 million 
people are outliving their cancer diagnosis and this group is expected to reach 19 million 
over the next 8 years. Five year cancer survival rates have consistently trended upwards 
since the NCI started collecting detailed data in 1975, from 48.9% between 1975-77 to 
68.7% between 2005-2011 (Howlader 2016).  
Nearly 80% of dangerous human malignant cancers originate from epithelial 
tissues that proliferate and migrate uncontrollably. (Ye and Weinberg 2015). A 
prevailing theory of carcinogenesis is “somatic mutation theory” (SMT) which postulates 
that individual epithelial cells become cancerous (i.e. proliferative and migratory) due to 
an accumulation of somatic mutations which activate oncogenes and lead to loss of 
function in tumor-suppressor genes. SMT theorists have accepted the idea that 
intercellular signaling and cell-cell interactions are important in the progression of 
carcinogenesis. Yet, proponents of the SMT have maintained their focus on the 
transformed epithelial cell, assuming the mesenchyme to be an accessory to 
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carcinogenesis initiation and metastatic invasion; a blind follower of the program 
initiated by the carcinoma cell. (Douglas Hanahan and Coussens 2012; Douglas Hanahan 
and Weinberg 2011) However much experimental evidence challenges this notion and 
indicates the true tumor microenvironment is not arranged in such a hierarchical 
structure (i.e. epithelium controlling stroma). Studies outlined in this review will show 
that signals originating in the stroma have the ability to differentiate and normalize 
transformed and “cancerous” cells. Further, epithelial cells within tissues can also direct 
the differentiation of neighboring epithelial cells and inhibit “cancerous” epithelial 
behavior. Thus, intercellular signaling at the tissue level may regulate the initiation of 
cancer. (Carlos Sonnenschein and Soto 2013; C. Sonnenschein and Soto 1999) 
It will be shown in this review that all epithelial cells are capable of motility, de-
differentiation and limited transdifferentiation within the epithelial lineage. In fact, all 
cells require continuous tissue-derived factors to maintain their differentiation and 
inhibit endogenous capabilities for growth and motility. Upon removal of these 
differentiation signals, any epithelial cell should be capable of reverting to a less 
differentiated stem-like cell. A current theory of metastasis, the epithelial to 
mesenchymal transition (EMT), requires epithelial cells dramatically change lineage and 
behave as isolated mesenchymal cells in order to metastasize. Instead it will be shown 
that upon loss of differentiating signals, epithelial cells will readily become migratory 
without losing epithelial identity. Therefore, the cardinal characteristics of metastasizing 
epithelial cells (stem-like and migratory) are not acquired properties upon genetic 
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mutations but rather endogenous characteristics “uncovered” upon loss of 
differentiating pressures from the tissue signaling environment.  
More attention has been paid to the study of oncogenes than to understanding 
cell-cell relationships within the tissue where particular neoplasms arise. (D. Hanahan 
and Weinberg 2000; Stratton, Campbell, and Futreal 2009) The focus on the genomics of 
the transformed cell (which is thought to have accumulated enough somatic mutations 
to begin acting autonomously) has overshadowed the interactions and signaling 
between cells in tissues where neoplasms arise. Recently, the stromal compartment has 
received more attention. (Douglas Hanahan and Weinberg 2011) SMT theorists however 
assume the stromal-epithelial and epithelial-epithelial interactions only become 
important once a cancer cell has transformed and acquired, through mutations, the 
ability to corrupt mesenchymal tissue cells. (Douglas Hanahan and Coussens 2012) 
Evidence presented below challenges this idea, and uncovers the striking influence of 
the tissue microenvironment on epithelial cells both during carcinogenesis and in the 
normal physiology. If differentiating inputs are removed, epithelial cells would exhibit 
properties of any autonomous or cancerous cell: uncontrolled proliferation and 
migration. Thus it is only through an imposed restraint by the environment that an 
epithelial cell does not exhibit a cancerous phenotype. Rather than properties acquired 
through the serendipity of somatic mutations, these characteristics are innate. A related 
question arises: what is a cancerous cell, and how is it different from a normal epithelial 
cell? What properties of a cancerous cell does an epithelial cell not possess? This review 
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will seek to argue that there are very little differences between normal and cancerous 
epithelial cells, and therefore the control of cancer progression occurs at the level of 
cell-cell interactions rather than within the genome of any one cell. 
The first section of this review will examine the influence of the surrounding 
mesenchyme and neighboring epithelium on differentiated epithelial cells in the adult 
animal, and seeks to address whether cell-fate decisions and the initiation of cancer may 
be controlled by these cell-cell interactions rather than by the genome of any one cell. 
 
How the Microenvironment Controls Epithelial Cell Fate 
What influence does the stromal compartment have on terminally differentiated 
epithelial cells? Graft experiments from the early 1980’s revealed that tissue 
microenvironments exert strong differentiating pressures on the epithelium of the adult 
animal. If bladder transitional epithelium is grafted onto the mesenchyme of the 
urogenital sinus in the adult Rat, the transplanted epithelium will transform its 
morphology to match the epithelium of the new environment. (Neubauer et al. 1983) It 
will form the branched secretory acinar glands characteristic of the prostate, as if the 
local environment dictated the identity of the cell rather than any genomic program of 
the epithelial cell itself. The grafted epithelium lost the morphology characteristic of 
bladder epithelium, membrane asymmetry and fusiform vesicles (used to increase or 
decrease membrane area as the bladder is stretched or relaxed), and gained a simple 
columnar morphology. These now columnar epithelial cells had gained features 
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consistent with secretory epithelium: nuclei and rough endoplasmic reticulum (RER) 
located basally and with Golgi complex and secretory granules located apically.  
This result suggests a number of vitally important principles of relevance to 
cancer regarding the relationship between the epithelium and stroma. First, how plastic 
is the identity of terminally differentiated epithelia, is it free to gain any identity a local 
might pressure it to become? Did the surrounding cells of the bladder keep the 
epithelium differentiated? One must conclude that the prostate tissue continually exerts 
differentiating pressures on its epithelium, pressures so strong that morphologically and 
physiologically distinct epithelial cells can be transdifferentiated into parenchyma of the 
host tissue. Do all tissues have this capability or is it unique to bladder and prostate? 
The answer may reveal a misunderstanding we have regarding how fixed cellular 
identity is and how autonomous individual cells are.  
Stromal influences on the epithelia of the adult breast are so strong that a wild-
type mammary microenvironment is able to drive the differentiation of male testicular 
epithelial cells into breast epithelium. When male seminiferous tubule epithelial cells 
that do not express the progesterone receptor (PR) were mixed with PR knockout 
mammary epithelial cells and co-injected into a cleared fat pad of a female animal, the 
lobular mammary epithelium developed normally. (Bruno et al. 2014) This process 
requires a functional PR receptor, and when either cell type was injected into fat pads 
alone, the lobules did not develop normally. Yet, when the two cell-types were mixed 
before transplantation, the resultant chimeric epithelium curiously expressed the PR 
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receptor. Polymerase chain reaction (PCR) detection of the Y-chromosome revealed that 
the testicular epithelial cells were now PR receptor positive. These testicular-epithelium-
derived PR positive mammary epithelial cells were also capable of self-renewal: when 
breast tissue from the first chimeric transplant were grafted onto the cleared fat pad of 
a second PR receptor knockout host, 40-50% of the luminal mammary epithelial cells 
were PR positive, maintaining the same PR receptor density as the original grafts. These 
effects were seen in both virgin and lactating mice.  
To further investigate the extent of differentiation of the transplanted cells, the 
expression mammary epithelial markers, receptor activator of nuclear factor κ ligand 
(RANKL) and E74-like ETS (E twenty-six) transcription factor 5 (Elf5), were tested. RANKL 
is a downstream target of the activated PR receptor and is thought to induce 
alveologenesis. RANKL stimulates the expression of the transcription factor Elf5 in 
neighboring PR negative epithelia. Dual staining of PR and RANKL, and PR and Elf5 
showed overlapping staining of PR and RANKL and non-overlapping staining of PR and 
Elf5, as expected. Thus, testicular derived PR positive cells expressed other markers of 
differentiated mammary epithelium, and were able to signal through a functional PR 
receptor to produce ligands that maintained differentiation of neighboring cells. (Bruno 
et al. 2014) These results indicate that epithelial identity is not fixed but rather a 
product of local environmental cues.    
Fibroblastic mammary mesenchyme seems to provide growth promoting cues 
required by the epithelium in order to form normal ducts, while the mammary fat pad 
7 
may provide inhibitory cues. Transplanting epithelial cells into fibroblastic mesenchyme 
without the fat pad leads to ductal hyperplasia. Further, epithelial cells transplanted 
into the fat pad without fibroblasts at the same age as the previous experiment (14-16 
days) fail to develop. (Sakakura, Sakagami, and Nishizuka 1982) This suggests factors 
from the both fibroblastic and fatty mesenchyme induce epithelial differentiation. As 
additional evidence for the strength of this epithelial/stromal interaction in mammalian 
breast development, if mammary epithelial cells of the same age as the above 
experiments are transplanted into the mesenchyme of the salivary gland, they will 
differentiate into the morphology of salivary gland epithelium. (Sakakura, Nishizuka, and 
Dawe 1976) However, these transplants maintained some aspects of mammary 
epithelial differentiation, synthesizing milk proteins in response to a post-pregnancy 
hormonal load. The principle message: the mesenchyme exerts a strong influence on 
epithelial differentiation, morphology and behavior. Further, epithelial identity may be 
more fluid and flexible than we currently understand, able to functionally and 
morphologically adapt to new tissue environments after being thought of as “fully 
differentiated.” 
Convincing evidence has proven the tissue environment has enormous impact on 
the behavior of a cancerous epithelium. The first series of experiments utilized co-
injection of transformed mammary epithelial cells and normal mammary epithelial cells 
into cleared fat pads. (Booth et al. 2011) Mouse mammary tumor virus promoter driven 
expression of neu- lacZ (the neu “oncogene” encodes HER2 also known as erbB2, which 
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is a member of the epidermal growth factor (EGF) family of receptor tyrosine kinases) 
generated neu positive tumors when injected in cleared fat pads alone. When co-
injected with wild-type MECs (mammary epithelial cells), the lacZ positive tumorigenic 
cells adopted a normal phenotype, interspersing within the epithelium along wild-type 
(WT) cells at all points along the ductal tree. These chimeric animals did not form 
tumors for the duration of the experiment (18 months), while animals injected with 
HER2/erbB2/neu cells alone formed tumors in 5-7 months. In chimeric animals Neu+ 
cells participated in ductal morphogenesis alongside normal cells, adopting 
differentiation markers based on their final position appropriately. Basally located Neu+ 
cells adopted a myoepithelial identity, as noted by expression of smooth muscle actin, 
while Neu+ cells located at the lumen expressed keratin8 as expected. In host animals 
that progressed to full term pregnancy, the putative “tumorigenic” cells were positioned 
among normal cells in mammary ducts and even localized to secretory lobules, adopting 
a functional secretory phenotype as noted by co-expression of the milk phosphoprotein 
β-casein. These formerly tumorigenic cells, induced to differentiate into morphologically 
and functionally normal epithelium in the wild-type mammary microenvironment, 
continued to express Neu/ErbB2/HER2. Importantly, ErbB2 receptor activation was 
silenced through some unknown mechanism (phosphorylated ErbB2 was not found). 
This mechanism to subdue the “oncogenic” signaling was epigenetic, as DNA sequencing 
did not reveal further DNA mutations or aneuploidy (which could have been caused by 
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cell-fusion with WT MECs). ErbB2 is not thought to homodimerize, but rather 
heterodimerize with epidermal growth factor receptor (EGFR), and phosphorylated 
EGFR (pEGFR) was identified in the chimeric mice indicating EGFR signaled normally. As 
further evidence co-injected wild-type MECs repressed intact ErbB2 signaling in the 
neighboring mutated cells, when chimeric breast tissue was dissected and sorted into 
individual cell populations, the Erb2+ cells were able to form tumors when they alone 
were transplanted into a new host. This indicates that the tumorigenic potential of 
these cells was retained, but signals from adjacent WT epithelial cells had silenced this 
capacity to form tumors without altering their genome. These, along with other results 
reviewed by Goruppi and Dotto, indicate that the tumor microenvironment provides 
important, perhaps even rate-limiting, limitations on the development of 
carcinogenesis. (Goruppi and Dotto 2013) 
The growth-constraining effects of surrounding tissue cells (stromal and 
epithelial) on the tumorigenic potential of individual epithelial cells is not confined to 
the breast. Carcinogen treated hepatocytes do not proliferate or colonize the liver when 
transplanted into a normal host. However, if the host liver was pretreated with the 
pyrrolizidine alkaloid retrorsine (RS), known to block cell-cycle progression, transplanted 
cells will progress to histologically confirmed hepatocellular carcinoma. (Laconi et al. 
2001) At 4 months’ post-transplantation, the livers of the RS pretreated hosts had 
doubled in weight. Yet if carcinogen treated hepatocytes were transplanted into normal 
hosts, livers did not change weight, nor did gross dissection reveal visible nodules. 
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Transplanted cells in normal host were found in clusters of no more than five cells, and 
this density did not increase from 2 to 4 months’ post transplantation. This again 
suggested that the wild-type host exhibited a restraint on the tumorigenic potential of 
the transformed and transplanted cells. Neoplasms only formed when the resident cells 
within the putative tumor microenvironment were altered, and the neoplasms formed 
independently of the genotype of the transplanted cells. This throws some doubt into 
the face of the SMT hypothesis of carcinogenesis, revealing that carcinogen-treated 
epithelial cells will not form tumors unless the microenvironment is disrupted. An 
important follow up to this study would be to probe the intercellular signaling 
mechanisms affected by RS treatment to identify what is secreted by normal liver cells 
that restrain the growth of transplanted carcinogenic cells. 
Is this result confined to the liver, or does an analogous mechanism exist in other 
tissues? Another group of investigators sought to define the target of carcinogens in 
mammalian breast tissue. (Maffini et al. 2004) Was it the mesenchyme, parenchyma, or 
both? The authors’ transplanted mammary epithelial cells, pretreated with either the 
chemical carcinogen N-nitromethylurea (NMU) or sham into cleared fat pads of host 
animals pretreated with NMU or sham. It was discovered that only the animals with 
stroma previously exposed to NMU developed neoplasms. Tumor formation did not 
depend on whether transplanted epithelial cells were exposed to the carcinogen, as 
when transplanted to a WT animal, tumor incidence was not higher in epithelial cells 
exposed to the carcinogen than vehicle treated epithelial cells. When transplanted into 
11 
WT hosts, NMU treated epithelial cells exhibited normal ductal branching and no 
evidence of neoplasm formation and WT epithelial cells formed tumors when 
transplanted into NMU-treated hosts. Further, the authors found the incidence of 
“tumorigenic” Ha-ras-1 mutations did not correlate with neoplasm development. The 
existence of Ha-ras-1 mutations were not predictive of tumor growth and transplanted 
epithelial cells which did not generate neoplasms were just as likely to harbor the 
mutation. In fact, the likelihood of harboring an activating Ras mutation was just as high 
in vehicle treated animals, or even WT animals randomly selected from the authors’ rat 
colony than in animals exposed to NMU. These results favor the hypothesis that 
mammalian neoplasms arise due to altered cell-cell interactions within a tissue, rather 
than the genetic status of any subgroup of epithelial cells. It also confirmed data 
presented previously that a wild-type tissue microenvironment can normalize 
“cancerous” epithelial cells. 
Other groups have similarly generated data separating “oncogenic” mutations 
and the onset of carcinogenesis. One group discovered that although transplanted Ha-
ras-1 mutated epithelial cells had a survival advantage over WT (increasing in-vivo 
relative abundance five-fold compared to WT as animals aged from 50-570 days), they 
were not selectively abundant in spontaneously formed tumors, and never constituted 
more than .001% of the epithelial tumor cells. (Cha et al. 1996) Another study 
investigated how hemi-body irradiation influenced neoplasm development of 
transplanted mammary epithelial cells that harbored p53 mutations in both alleles 
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(COMMA-D). (Barcellos-Hoff and Ravani 2000) When injected into non-irradiated hosts, 
the COMMA-D cell line differentiated normally into ductal outgrowths, produced milk 
proteins and did not form tumors. However, exposure to hemi-body ionizing radiation 
before transplantation preferentially increased the tumorigenic potential of these p53 
mutated epithelial cell line only on the side of the body exposed to the radiation. The 
study confirmed data from Maffini et al., Booth et al., and Laconi et al. that the tissue 
environment determines whether neoplasms developed, not the genetic makeup of the 
epithelial cells that will go on to populate the tumor. The above examples illustrate how 
the function and signaling of the tissue microenvironment may be an influential driver 
of neoplastic formation, rather than the genetic makeup of any particular epithelial cell.   
The results above are similar to a study performed more than forty years ago. In 
a classic example of the power of the microenvironment to influence or normalize 
aberrant behavior of malignant embryonic cells, teratocarcinoma cells taken from an 
intraperitoneal tumor can be transplanted into a developing embryo at the blastocyst 
stage to generate completely normal animals. (Brinster 1974) Sixty offspring were raised 
to adulthood using this experimental protocol with no observable defects. No tumors 
formed in the hybrid animals, although one animal exhibited a patch of agouti hair that 
must have been caused by the chimerism.  
If tissues control epithelial cell differentiation, changes in tissue requirements 
could lead to a reprogramming or modulation (transdifferentiation) of cell fate under in-
vivo conditions. Indeed, following injury to ductal cells in the mammalian liver, 
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differentiated hepatocytes will switch lineage, downregulate hepatocyte markers, 
upregulate ductal markers and incorporate into biliary ducts actively being repaired. 
(Tarlow et al. 2014) Although most of the repairing cells were ductal in origin, a 
significant portion (up to 39%) were hepatocyte derived. Once the injury was resolved, 
the same hepatocytes that were driven by the injury to populate ducts, became 
exclusively induced into the hepatocyte lineage. This indicates that tissue injury can 
modulate the local signaling environment and dictate the differentiation of the cell. 
Once the injury resolved, cells were allowed to resume their normal differentiation 
program. Thus injury produced signals that drove the transdifferentiation of existing 
hepatocytes into ductal cells as they are needed. The data suggest that if ducts are 
functioning properly, hepatocytes will be made, while if ducts sustain injury, they will be 
repaired before additional hepatocytes are produced. These experiments were 
successfully reproduced using human hepatocytes. This adds evidence to the idea that 
cell-fate decisions are decided by cell-cell signaling within tissues, if these signals are 
interrupted, aberrant or incomplete differentiation could lead to carcinogenesis. 
A commonly used mouse model of Ras based lung and liver tumorigenesis is 
urethane (ethyl carbamate) exposure. Ras gain-of-function mutations are thought to 
underlie many cancers, and it is thought that urethane exposure induces mutations in 
Ras leading to tumorigenesis. (Pylayeva-Gupta, Grabocka, and Bar-Sagi 2011) The 
mechanism is thought to be through a P450 metabolite (vinyl carbamate epoxide) that 
forms etheno-adducts in DNA. (Benigni and Bossa 2011) Presumably, amino acid 
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substitution follows alkylation at a conserved mutational site in codon 61 leading to H-
Ras or K-Ras gene activation. However, the activation of the downstream targets of Ras, 
MEK and ERK only became apparent 30 days after urethane exposure. (Yano et al. 1999) 
In a different representative study of urethane induced tumorigenesis, tumors appeared 
16 weeks after exposure. Ethenobases are repaired by base excision repair, involving 
DNA N-Glycosylases. The most common DNA adduct formed by urethane exposure, 7-
(2-oxoethyl)guanine, does not lead to either thymine or adenine miscoding. (A. Barbin, 
Laib, and Bartsch 1985; Holt et al. 2000) Instead, the εA (1,N6-ethenoadenine) and εC 
(3,N4-ethenocyostine) exocyclic adducts formed are thought to be the initiators of DNA 
lesions, despite occurring at a much lower frequency. In a study by Barbin et al., the 
focus was on adenine alkylation because of its ability to form the AT→TA transversions 
within exon 61 of Ras that were observed in previous studies of urethane treated mice. 
The base excision enzyme APNG (Alkyl Purine DNA N-glycosylase) repairs adenine, so 
the authors investigated tumorigenesis in APNG-/- (null) mice. Not surprisingly, lung and 
liver tissue from APNG-/- mice possessed an increased number of alkylated adenine 
nucleotides, and these insults persisted longer than APNG competent mice. Lung tissue 
of APNG null mice exhibited a 2-fold increase in ratio of εA/A at 6 hours’ post-exposure. 
By 96 hours’ post-exposure, the εA/A ratio of APNG-/- null mice had dropped to 1/3rd of 
the 6-hour peak, while by this time almost all damaged DNA was repaired in WT mice. 
By extrapolation, APNG-/- null mice would have cleared lung mutations by 144 to 168 
hours post treatment, almost twice the amount of time taken by APNG competent mice. 
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Despite clearing almost all DNA damage from the mutagen by 96 h (WT) or 168 h (APNG-
/-), liver tumors did not appear until a full year after mutagen exposure, even in the 
highest dose group. Significantly, the lack of DNA repair mechanisms did not increase 
the likelihood of liver tumor formation. No increase in tumor susceptibility was 
observed in the liver or lung in DNA-repair deficient mice. Even in the high dose group, 
lung tumors were not observed in any mice (APNG competent or not). Between 15 and 
18 percent of hepatocytes were apoptotic 24 hours after urethane exposure, as 
measured by the TUNEL assay, but no difference was seen between groups. Cell 
proliferation, measured by BrdU incorporation, peaked 24-hours post-exposure, but 
again was not different between groups. (Alain Barbin et al. 2003) When these results 
are taken together with the time-course of Ras cascade activation, it provides some 
indirect evidence suggesting that in the urethane model of Ras based carcinogenesis, 
DNA damage leading to Ras hyperactivation may not the mechanism of tumor 
formation. It suggests that urethane may modulate other inhibitory signals imposed 
upon the epithelium by the tissue. 
Given the evidence above, it is reasonable to assume that the surrounding tissue 
has a profound influence on the differentiation and thus on the tumorigenic potential of 
epithelial cells. As discussed, this effect is so strong that “cancerous” epithelial cells can 
be induced to differentiate into phenotypes indistinguishable from normal tissue. What 
about the induction of carcinogenesis? Some proponents of the SMT may dismiss the 
value of non-mutagenic cell-exogenous influences on neoplasm development, but these 
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studies give evidence to support the stroma as capable of transforming genetically 
normal epithelium into a cancerous phenotype. As carcinogen exposure appears to 
initiate neoplasm formation only when the entire tissue was treated, not when only 
epithelial cells are treated and transplanted into normal hosts, do we need to redefine 
what the mechanism of action of a carcinogen is? To wit, it was known that the iris 
epithelium of newts could transform into a new lens after injury. However, only the 
dorsal portion of the iris epithelium was capable of this regeneration, not the ventral. 
Yet, when the ventral cells were treated with a known mutagen N-methyl-N’-nitro-N-
nistrosoguanidine (NG), they became capable of forming lenses instead of forming 
tumors. (Eguchi and Watanabe 1973) Treatment with a known carcinogen re-
programmed this portion of the iris epithelium to allow it to induce a differentiation 
program it had previously lost the ability to evoke. Should we rethink our understanding 
of how carcinogens operate, beyond somatic mutations and into reactivating signaling 
processes potentially akin to development? 
 
What then is a Cancer Cell? 
If normal epithelial cells can be induced to form tumors by an activated 
microenvironment and “oncogene” activated epithelial cells can be normalized by a 
wild-type microenvironment, maybe “cancerous” epithelial cells are not much different 
than wild-type epithelial cells. Further, if the existence of DNA mutations within an 
epithelial cell can be masked by inhibitory signaling within a tissue, maybe DNA 
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mutations within epithelial cells are not the rate-limiting cause of cancer. Perhaps 
“cancerous” epithelial cells are no different than normal epithelial cells. Data presented 
above suggests the true driver of carcinogenesis may be the tissue microenvironment, 
independent of tumor cell genetics. Further, it has been shown that somatic mutations 
are common in WT epithelial cells, and cancer derived epithelia only show a 2-fold 
increase in mutation rate. (Martin et al. 1996) Evidence presented so far and in 
upcoming sections may indicate that all epithelial cells are all potentially “carcinogenic” 
(endowed with the abilities to migrate and grow/divide) and neoplasm occurrence may 
be determined by growth and motility limiting pressures originating from the tissue 
environment. Therefore, the question remains: what is unique about cancer cells?  
The machinery for cell division, and cell cycle control is conserved across all 
eukaryotic cells, from human cells to single cell protozoa, let alone between normal and 
cancerous human cells. (Alberts 2008) The main difference in transcriptional profiles 
between single celled organisms and multicellular eukaryotes is the expression of 
factors that induce differentiation, sub-specialization within multicellular organisms and 
the concomitant inhibition of proliferation and motility. (Xia et al. 2006) Both 
“cancerous” and normal epithelial cells have the capacity for proliferation, growth and 
migration. Thus, a unique proliferative and motile capacity that defines cancer cells as 
radically different from their normal counterparts should be revisited. Motility does not 
differentiate cancerous and normal epithelial cells. Differentiated epithelia are assumed 
to be stationary, but it will be shown that epithelia are capable of collective, adhered 
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migration. (Matsubayashi et al. 2004; Friedl and Gilmour 2009) Furthermore, the 
mechanism of this endogenous ability is conserved within metastasizing epithelial cells. 
(Friedl et al. 2012)  
The profound adaptation of multi-cellular organisms is inhibition of the basic 
cellular processes of division, growth and motility. In-vitro experiments discussed later 
by Hay and later Weinberg taught us much about how cells grow, move and proliferate, 
but not why. Cancer cells proliferate and move, not because they are unique, but 
because they are historically programmed to behave this way, like all eukaryotic cells. 
(Binamé et al. 2010) Experiments regarding the “reversibility of the malignant 
phenotype” give strong evidence that cell phenotypes are context-dependent, and the 
cancer cell is again not unique in that aspect (Hendrix et al. 2007; Carlos Sonnenschein 
and Soto 2011; Kenny and Bissell 2003) Understanding carcinogenesis requires an 
investigation into what signaling context has driven a particular cell to be “cancerous.” 
Furthermore, the “cancerous” epithelial phenotype, as will be outlined below, is not 
dramatically different from a normal epithelial phenotype. It follows that we should 
supplement the investigation into what exogenous factors induce motility and 
proliferation (almost everything), with what factors once removed release the epithelial 
cell from inhibition, across the fine line between growth and malignancy.  
It may be a mistake to accept the notion that differentiation and quiescence is 
the default state of cells. The reality is that human cells are genetically programmed to 
move and divide, similar to our single-celled amoeboid ancestors. The emergence of 
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metazoan from solitary, wandering single cells must have involved inhibition of 
characteristic behaviors of single cells: unchecked growth in ample nutrients and 
motility to find new nutrients. (Sebé-Pedrós et al. 2013) Analysis of stem cells has 
bolstered this line of reasoning: they were shown to carry an innate program for 
division, while differentiation required exogenous factors. (Ying et al. 2008) What is 
understood as the default behavioral state of human epithelial cells, immobility and 
quiescence, does not follow from evolutionarily logic, but must be something 
exogenously induced in order to prevent chaos in a multi-cell, multi-tissue organism. 
 
Is Cancer the Result of an Interruption of Microenvironmental Differentiation Cues? 
 
Consistent with the idea that differentiation and quiescence must be 
exogenously maintained, recent work in the mammalian airway epithelium revealed 
that selective ablation of basal stem cells led to increased proliferation and subsequent 
de-differentiation of neighboring luminal secretory cells in-vivo. The secretory cell 
population induced to de-differentiate (now basal-cell-like) persisted in its new 
phenotype over a 2-month experiment. These cells were functionally and 
morphologically equivalent to endogenous basal stem cells, able to differentiate into all 
three airway epithelial cell types (basal, secretory, ciliated) and repopulate them 
appropriately after injury. (Tata et al. 2013) Direct, or near-direct contact between the 
basal cells and the differentiated cells was required to prevent de-differentiation in an 
ex-vivo sphere forming assay of stemness. Further, loss of basal cell contact led to 
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secretory cell proliferation. The factor provided by the basal cells to the secretory and 
ciliated cells to maintain differentiation may signal through hippo, a family of 
serine/threonine kinases that phosphorylate and inactivate YAP signaling. While the 
factor provided by the differentiated cells to the basal cells may activate YAP signaling, 
as YAP was required for basal stem cell maintenance, and YAP loss led to the 
differentiation of basal cells into secretory cells. Conversely, YAP overexpression led to 
basal cell proliferation and inhibition of secretory/ciliated cell differentiation. (Zhao et 
al. 2014) These studies provide supporting data to the tenet of this thesis: without 
restraining influences provided by a tissue microenvironment, cells will revert to their 
default state: uncontrolled growth and replication. Thus, in normal airway physiology, 
factors secreted by differentiated cells (ciliated and secretory) maintain the stem-like 
state of the basal cells, and factors from the basal cells maintain the differentiation state 
of the ciliated and secretory cells. This is entirely consistent with the local environment 
(in this case neighboring epithelial cells) determining the identity of any individual 
epithelial cell within a tissue. Further, the true state of cells in isolation may lie closer to 
stemness rather than quiescent differentiation as assumed by SMT theorists. (Douglas 
Hanahan and Weinberg 2011) Growth and motility are not acquired properties after 
insults to the genome, they are endogenous properties of all cells that must be inhibited 
within multicellular tissues. Cell specialization is exogenously driven by tissue-derived 
factors external to any one cell, and in order to maintain differentiation and inhibit 
carcinogenesis, signals must be continually provided.  
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Intercellular signaling in the mammalian intestinal epithelium provides another 
example of the external signals required to maintain the differentiation state of 
epithelial cells. (Tetteh et al. 2016; van Es et al. 2012) Paneth cells have a relatively long 
life-span and act to nourish Lgr5+ stem cells, providing wingless/integrated (Wnt), Notch 
and EGF signaling. Lgr5+ stem cells differentiate into enterocytes or secretory cells as 
they migrate up the crypt toward the intestinal villus. (Tetteh et al. 2016) Notch 
signaling is crucial to this lineage selection within the intestinal epithelium. Upon ligand 
binding to a Notch receptor, sequential proteolytic cleavage occurs to initiate receptor 
activation. A disintegrin and metalloproteinase (ADAM) first cleaves the S2 site to 
release an extracellular domain, while the Notch extracellular truncation domain (NEXT) 
remains membrane-adhered and contains an intracellular signaling domain Notch 
intracellular signaling domain (NICD). (Kopan and Ilagan 2009) Subsequent γ-secretase 
cleavage at the S3/S4 sites of the transmembrane domain release NICD and allow it to 
translocate to the nucleus. NICD binds the DNA-interacting protein centromere binding 
protein 1 (CBF1), suppressor of hairless, Lag-1 (CSL) stimulating the recruitment of other 
factors (Mastermind/Lag-3 and mediator complex subunit 8-MED8), which together 
activate expression of downstream target genes. If Notch1/2 receptors are activated in 
the stem cells, Hes1 expression increases, which in turn inhibits the expression of the 
Math1 transcription factor that is vitally important for secretory lineage differentiation. 
Blockade of Notch allows Math1 expression and routes stem cells into the secretory 
lineage. (van Es et al. 2012) Notch activation through either Dll1 or Dll4 inhibits markers 
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of cell stemness in the crypt such as olfactomedin 4 (Olfm4), follistatin-related protein 1 
(Fstl1) and tumor necrosis factor superfamily member 19 (Tnfsrf19). Radiation damage 
to the crypt induced apoptosis and depleted Lgr5+ stem cells. (Tetteh et al. 2016) 
Interestingly this reverted Dll+ secretory precursor cells to Lgr5+ stem cells. This ability of 
intestinal epithelial cells to return to a de-differentiated state was thought to be 
restricted to the relatively rare secretory cell types. Yet, evidence from Tetteh et al. 
reveals this property can be generalized to committed alkaline phosphatase (Alpi+) 
enterocyte precursors as well, as would be predicted from the hypothesis that tissue-
specific signals determine differentiation state. Similar to secretory precursors, these 
Alpi+ cells dedifferentiated into Lgr5+ stem cells when the endogenous stem cells were 
ablated. These putative stem cells were able to repopulate all epithelial cells of the 
intestinal villi, including enterocyte and secretory cell lineages. Interestingly, 3 days after 
exiting the crypt the enterocytes were no longer able to dedifferentiate, suggesting a 
signal emanating from the crypt may locally retard the differentiation program and 
facilitate dedifferentiation. The results also suggest, similar to the mammalian lung, that 
signals from a tissue stem cell compartment drive differentiation of nearby epithelial 
cells. Further, selective loss of stem cells leads to dedifferentiation of mature epithelial 
cells until the stem cell progenitor pool is successfully replaced. 
Of fundamental interest to the thesis of this review, which challenges the notion 
that mutations in “oncogenes” must occur in order to activate fundamental cellular 
behaviors, the authors induced mutations in the APC (adenomatous polyposis coli) and 
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Ras pathways. (Tetteh et al. 2016) These mutations are thought to act synergistically 
during colorectal cancer formation. Epithelial cells harboring these mutations were only 
able to form tumorigenic organoids in-vitro but did not yield any neoplasms/adenomas 
in-vivo, where signals emanating from the surrounding tissue would be predicted to 
inhibit neoplasm formation while driving differentiation and limiting the size of the 
progenitor pool. Mutations in the APC “tumor suppressor” gene and related Wnt/β-
catenin “oncogene” are thought to initiate progression to neoplasia and colon polyp 
formation. Loss of function mutations in APC have been observed in 60% of colonic 
adenomas and carcinomas. (Janssen et al. 2006) Constitutively active Ras (KRAS) 
“oncogene” mutations are thought to drive tumorigenic progression and growth, 
synergistically enhancing Wnt hyperactivation in APC null mutants. Mice with mutations 
in both of these genes (KRAS and APC) are observed to accumulate 10-fold increase in 
tumor burden and a corresponding increase in tumor invasiveness. However, in the 
Tetteh et al. study, dual mutations in APC and KRAS only resulted in in-vitro tumor 
formation, whereas in-vivo adenomas did not form. (Tetteh et al. 2016) The crucial 
distinction between studies from Janssen et al. and Tetteh et al. could be the presence 
of potential off-target effects of the KRAS and APC mutations. This is a vital distinction, 
as mutations in multiple cell types could lead to disruptions in cell-cell interactions 
which normally inhibit neoplasm formation; i.e. factors exogenous to the cell population 
being studied. The study from Janssen et al., which reported APC and KRAS mutation 
drove in-vivo tumorigenesis, used markers to target mutations that are not exclusive to 
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enterocytes (DNA repair helicase Xpb1 and Villin). (Janssen et al. 2006) While the study 
which did not show in-vivo tumorigenesis, the enterocyte-specific protein Alpi was used, 
which unlike Xpb1 and Villin was not expressed in Lgr5+ stem cells or secretory precursor 
Dll+ cells. (Tetteh et al. 2016; Kim, Escudero, and Shivdasani 2012) Thus in Janssen’s 
study, Wnt and Ras hyperactivation was not restricted to the enterocyte lineage, but 
rather all intestinal epithelial lineages. Therefore, the study showing overactive Wnt and 
Ras led to tumorigenesis could have resulted in signaling dysfunction at the tissue level, 
leading to removal of differentiating pressures or loss of inhibitors of proliferation and 
motility that emanate from neighboring epithelial or mesenchymal cell types. However, 
this must be reproduced in other tissues and models, as other studies have shown 
cooperativity between APC and Ras mutations led to increased tumorigenesis. (Davies 
et al. 2014; Sánchez-Rivera et al. 2014)  
Interactions between mammalian Schwann cells and the neurons they support 
provide another example of the requirement for continual exogenous pressures to 
maintain differentiation state. In myelinating Schwann cells, cyclic AMP (cAMP) signaling 
is required to differentiate and induce a myelinating phenotype. During neuronal injury, 
signals mediated by protein kinase A (pKA) from the neuron to the Schwann cell are lost, 
resulting in reduced cAMP levels in the Schwann cell. This reduction allows Schwann cell 
dedifferentiation toward a state that is thought to promote regeneration of the injured 
neuron. (Merrell and Stanger 2016; Monje et al. 2010) Interestingly, the high levels of 
cAMP required for differentiation blocked the ability of mitogens/RTK (receptor tyrosine 
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kinase) ligands such as Neuroregulin, platelet derived growth factor (PDGF), insulin like 
growth factor (IGF), and fibroblast derived growth factor (FGF) to induce cell-cycle 
progression or proliferation of the Schwann cell. If cAMP levels were exogenously 
reduced in the Schwann cell, its ability to progress through the cell cycle was restored 
and the cell-cycle and growth arrest phenotype induced by cAMP was lost. Thus cAMP 
levels determined the proliferative capacity of the cell, not the presence or absence of 
“growth factors.” This distinction is raised to contract the view propagated by SMT 
theorists that neoplasm formation occurs as the result of activating mutations in 
“growth factors,” which implies the default state of cells is quiescence. Schwann/neuron 
interactions give further evidence that quiescence is exogenously maintained, in this 
case through cAMP levels, while no amount of growth factor activation could overcome 
the inhibition provided by a neighboring cell. The Schwann cells did not lose all 
differentiation marker expression upon dedifferentiation, suggesting cAMP levels 
represented a fine-tuning of differentiation status, rather than a drastic change into a 
progenitor cell. Dedifferentiation did coincide with loss of intracellular vacuoles, a 
reduction in size and the appearance of cytoplasmic processes (perhaps used to drive 
motility to find another neuron if the injured neuron did not recover). These cells did 
not automatically initiate cell-cycle entry under in-vitro conditions of nutrient starvation. 
Instead, the Schwann cells became “competent to resume proliferation” when nutrients 
or mitogens were added to the media.  
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The ability of a Schwann cell to myelinate is determined through an antagonistic 
relationship between a transcriptional regulator that promotes myelination Krox-20 and 
an inhibitory transcriptional regulator c-jun. Data revealed increased intracellular levels 
of cAMP repressed c-jun and activated Krox-20, providing a mechanism of cAMP 
regulation of Schwann cell differentiation. (Monje et al. 2010) Presumably an inhibitory 
signal constitutively released from nearby neurons acted through cAMP and Krox-20 to 
maintain the differentiated state of the Schwann cell. Upon injury to the neuron, this 
signal was eliminated, leading to reduced cAMP levels and Krox20 levels while 
disinhibiting c-jun, leading to a dramatic change in Schwann cell morphology and 
function. This transition is thought to promote the regeneration of the neuron, 
providing another example of how cell-mediated inhibition of growth and stemness 
characterizes tissue function. (Merrell and Stanger 2016) This gives further support to 
the thesis that in the default state, cells are nothing like the quiescent well-behaved 
static entities we believe they are, but instead the dormant phenotype must be 
exogenously maintained. Considering the possibility that tissue-specific terminal 
differentiation and growth-arrest is an imposed phenotype, the identification of factors 
that mediate this signaling could be used to develop more effective cancer treatments.  
Coordinated migration is another behavior within the normal repertoire of 
epithelial cells that must be inhibited by differentiating factors in order to maintain 
tissue order. E74-like factor 5 (Elf5), of the ETS family of transcription factors, could be 
one such factor. In the mammary epithelium it acts to maintain epithelial phenotype 
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and suppress epithelial migration. Loss of Elf5 resulted in a disorganized mammary 
epithelium and prevented alveologenesis and lactation. Elf5 knockout in luminal 
epithelial cells resulted in downregulation of the epithelial differentiation marker E-
cadherin and upregulation of migratory markers like vimentin and nuclear snail2. Other 
markers that indicated a loss of epithelial phenotype were transcriptionally upregulated 
like Twist and Zeb following Elf5 knockdown. (Chakrabarti et al. 2012) Snail2 expression 
is activated in other motile cells like macrophages infiltrating an inflamed colon or 
during an acute tissue injury, in a transforming growth factor beta 1 (TGF-β1) dependent 
manner. SiRNA knockdown of snail also repressed invasion in a macrophage cell line in-
vitro. (Hotz et al. 2010) Twist binds to the snail promoter and induces its expression, and 
snail induction is required for twist induced metastasis and motility. (Casas et al. 2011) 
As further evidence that Elf5 is required for epithelial phenotype maintenance and 
differentiation, Elf5 levels were reduced in epithelial breast cancer cell lines that had a 
more invasive and migratory phenotype, and overexpression of Elf5 suppressed a TGF-β 
induced migratory transcription profile in normal mammary epithelial cells. Enforced 
stable expression of Elf5 in the highly invasive and motile MDA-231 breast cancer cell 
line induced markers of differentiated epithelium, including a reversion to cuboidal 
morphology (compared to MDA-231’s characteristic spindle-like appearance), 
upregulation of β-catenin localized to cell-cell junctions, and increased appearance of F-
actin cables and tight junctions’ characteristic of epithelia. Using chromatin 
immunoprecipitation, it appeared Elf5 directly bound to a conserved region within the 
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snail2 promoter, which indeed contained a putative Elf5 binding motif, suppressing its 
expression. Importantly, Elf5 overexpression greatly decreased lung metastasis nodules 
in a xenograph model using the highly lung-invasive epithelial breast cancer cell LM2 
subline of MDA-231. (Chakrabarti et al. 2012)  
Activating or inducing positive regulators of Elf5 expression could lead to anti-
metastasis treatments for mammary epithelial cancers. As noted previously, Elf5 
expression is not generated cell-autonomously, but rather induced by local cues 
(Progesterone receptor signaling stimulates RANKL expression, and RANKL induces Elf5 
in neighboring epithelial cells). Interrupting RANKL signaling released the inhibition on 
epithelial cell migration. A proposed crucial differentiating feature between cancerous 
epithelial cells and normal epithelial cell is migratory ability. If interrupting a single 
signaling pathway, in the absence of somatic mutation, causes WT epithelial cells to 
behave like cancer cells, again how different are cancer cells from normal cells? Could it 
be that many or all the phenotypic characteristics we assign to cancerous epithelial cells 
are actually inherent in normal epithelial cells? According to the experiment results 
reviewed above, these characteristics needn’t be generated de-novo by a cancerous 
epithelial cell, but rather their existence is revealed upon removal of differentiating 
factors.  
Intercellular signaling in the mammalian airway epithelium, intestinal crypts, 
mammary epithelium and between the Schwann cell and peripheral neurons indicate 
that local signals provide constant inhibitory cues to maintain differentiation and 
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prevent proliferation and motility. Is it any wonder that if these local cues become 
impaired, excessive epithelial growth or metastatic dissemination could occur, perhaps 
without the need to invoke genomic alterations? Like growth inhibition, motility arrest is 
assumed to be a property fundamental to most epithelial cells. The next section will 
argue that epithelial motility is a default cellular program, not something that must be 
induced or acquired through genetic alterations.  
 
The Morphological Plasticity of Epithelial Cells-Migrating Groups 
As argued above the default state of epithelial cells is profoundly misunderstood, 
but so is the range of normal behaviors these cells are capable of. In the study of cancer, 
cell-type conversions (into dramatically different lineages) are cited to explain “newly 
acquired” behaviors of epithelial cells, such migratory ability. (Ye and Weinberg 2015) 
This section serves to broaden the range of morphologies and actions that are within 
the behavioral range of non-transformed epithelial cells. It will be shown that common 
observations assigned solely to “cancerous” cells, like the migratory ability required for 
metastasis, behaviors within the repertoire of normal epithelial cells.  
The morphological variability of differentiated epithelium is readily observed 
during wound healing. In the initial response to tissue injury, epithelial cells migrate as a 
collective sheet to close wounds. (Friedl and Gilmour 2009) They behave as a 
supracellular “micro-tissue” that exhibits collective polarity, coordination, intercellular 
contact and communication, and the ability to migrate directionally. Similar to a 
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physiological tissue, epithelial cells in this arrangement develop sub-specializations: 
pathfinder cells (aka tip cells-to be discussed later) or following cells (aka stalk cells). The 
tip cells exhibit bipolarity: the leading edge of the cell explores the environment, 
responds toward nutrient gradients and extends lamellipodia, filopodia or pseudopodia 
(finger-like cytoskeletal membrane-bound projections) to create focalized adhesions to 
the substratum and propel the cell forward. These tip cells use actinomyosin contraction 
to generate force and movement, all while staying adhered to subsequent stalk cells 
creating an epithelial sheet. Previously thought to be passive bystanders, stalk cells have 
been shown to aid forward progression and exhibit “cryptic” lamellipodia which are 
hidden from view using conventional top-down imaging, but are readily apparent when 
the cell sheet is observed laterally or when forces produced by the migrating cohort are 
calculated (this review will return to data supporting this topic shortly). The forward 
movement of tip cells leading an epithelial collective and the motility of single cells 
utilize conserved systems. These include actinomyosin rearrangements using small 
GTPases Ras homolog (Rho), Ras Related C3 Botulinum Toxin Substrate 1 (Rac) and cell 
division control protein 42 (Cdc42), each part of the Ras superfamily of guanosine 
triphosphate (GTP) hydrolases, and their effector kinases such as Rho kinase (ROCK). 
(Khalil and Friedl 2010; Amano, Nakayama, and Kaibuchi 2010; Vaezi et al. 2002; 
Bustelo, Sauzeau, and Berenjeno 2007) Leading cells seem to utilize a greater diversity 
of extracellular matrix (ECM) interacting integrins to migrate the novel environment. 
They also modify ECM components with pericellular proteolysis using membrane bound 
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matrix metalloproteinases such as MT1-MMP/MMP14. This may serve to homogenize 
the ECM substrate and ease the forward progression of following stalk cells, allowing 
them to express a more restricted array of ECM interacting integrins. (Friedl and 
Gilmour 2009) In order to move as a unit, cell-cell communication is vital to coordinate 
cell behavior within the group. Studies have shown that mitogen activated protein 
kinase activation (MAPK), starting at the leading edge, can proceed rearward in a wave-
like manner passing from cell to cell. (Nikolić et al. 2006) Further examination revealed 
that the MAPK signal activation swept rearward in two waves. The first wave was fast 
and brief. Activation peaked in under 5 minutes and dissipated by 20 minutes, save for 
the first row of migrating cells. The second wave gradually built strength and distance 
from the wound margin, reaching 600 µm rearward by 4 hours. Presumably the first 
wave was a priming step, as it occurred much too fast to be associated with movement, 
while the second wave corresponds with frank epithelial sheet migration. Specific 
inhibition of extracellular signal regulated kinase (ERK2 aka MAPK1) using a kinase-dead 
dominant negative mutant, significantly reduced post-wounding migration. 
Furthermore, as the wound closed, and cells stopped moving, ERK was inactivated. 
Interestingly, serum was not required after wounding for ERK1/2 activation or 
migration, indicating that ERK1/2 was activated independent of growth-factor 
stimulated signaling. ERK1/2 activation also seemed to occur without protein synthesis 
or transcription, as cyclohexamide nor actinomycin-D treatment did not disrupt motility. 
Src kinase-mediated activation of ERK in epithelial cells has been found during studies of 
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the hepatocyte growth factor and epidermal growth factor receptor tyrosine kinase 
(ligand-receptor: HGF-cMET, EGF-EGFR)-mediated formation of focal complexes 
(adhesion precursors) and focal adhesions (sites of mechanical force transduction 
connecting the actin cytoskeleton to the ECM) within lamellipodia required for 
movement. Src kinase inhibitors PP1 and PP2 were effective in blocking the movement 
of the cell sheet and the second wave of MAPK activation during the wound healing 
studies, but did not affect the first wave of activation, suggesting each wave is 
controlled independently. (Matsubayashi et al. 2004) In that same study, activated ERK 
was not only found in the nucleus, consistent with its defined role as a transcription 
modulator, but also within the leading edge of lamellipodia. Inside lamellipodia ERK 
associated with paxillin, a docking site for multiple proteins at focal 
complexes/adhesions, including vinculin and FAK (focal adhesion kinase). The 
ERK/paxillin association was precipitated through Src kinase phosphorylation of paxillin. 
Interestingly, activated ERK-paxillin association was most strongly noted within 10 
minutes of RTK activation. By 30 minutes, focal complexes matured to focal adhesions, 
yet ERK activation and ERK-paxillin co-localization was much reduced. However, paxillin 
(without ERK) remained localized at focal adhesions through 180 minutes after RTK 
stimulation, suggesting ERK association is a priming step. Interestingly, mere plating of 
epithelial cells on a fibronectin medium resulted in paxillin incorporation into adhesion 
complexes but resulted in less sustained ERK activation. Through a series of convincing 
experiments, the authors concluded that Src acted to phosphorylate paxillin at Y118 and 
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this residue served as the site for ERK association. Paxillin was proposed to serve as a 
scaffold for ERK activation by binding its activators Raf and MEK. Mutating the Y118 ERK 
binding site on paxillin abolished RTK mediated cell motility in-vitro and disrupted the 
formation of focal adhesions necessary for force transduction and motility. (Ishibe et al. 
2003) Identification of these signaling cascades provides an array of targets to inhibit 
collective epithelial cell migration and is supremely relevant to metastasis treatment by 
generating targets for drug development. 
As noted above, in a migrating epithelium there are leading cells and following 
cells. A misunderstanding is that leading cells are uniquely migratory, and the following 
cells are passively pulled along. (Friedl et al. 2012) A fascinating study in Nature Physics 
showed that nearly all cells in a migrating epithelial sheet contribute to traction forces. 
(Trepat et al. 2009) When they grouped cells by distance from the leading edge, and 
plotted the forces generated by each of these groups on the underlying substrate, all 
groups of cells fit in a single Gaussian curve. This indicates that leading edge cells do not 
generate more forces than cells away from the leading edge, and all cells contribute to 
collective movement.  
Additional studies have given morphological support to this concept of uniform 
traction generation. One such study showed that cells on the interior of the migrating 
epithelium (stalk cells) extended lamellipodia to interface the substratum while also 
maintaining cell-cell adhesions. Further, there seem to exist behavioral plasticity within 
the migrating collective. Cells following the leading edge of an invading cluster 
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proteolytically degraded the walls of tubes formed by leading cells to facilitate passage 
of subsequent cells of the epithelial collective. (Friedl and Wolf 2008) Morphological 
plasticity was also characteristic of the leading cells. In a modified wound healing assay, 
leader cells were able quickly switch between different phenotypes. When presented 
with a free surface, the epithelium behaves as if there has been a wound, collectively 
migrating over the free substratum. As soon as leader cells at the front edge of 
migrating collective come in contact with another group of epithelial cells, they modify 
their morphology, reduced membrane ruffling and retracted lamellipodia, becoming 
indistinguishable from the other cells in the collective epithelium. Elevated extracellular 
calcium was required to form these adhesive contacts between two migrating epithelial 
sheets. (Poujade et al. 2007) This assay also provided evidence that an actual wound or 
a chemokine/growth factor gradient was not needed to induce epithelial migration, but 
merely a free surface upon which to migrate. It revealed that epithelial cells can 
undergo dynamic morphological changes, cycling between stationary to migratory in 
short periods of time. Further, video microscopy revealed that the development of cell-
cell adhesions during epithelial tissue formation used transient and searching 
filopodia/lamellipodia to contact neighboring cells and to ultimately form adhering 
junctions at the precise locations where the membrane extensions contacted 
neighboring cells. (Vaezi et al. 2002) So, not only do all cells in a migrating epithelium 
contribute to the propulsion of the group, epithelial cells do not require exogenous 
growth factor stimulation or genetic mutations in order to exhibit migratory behavior. 
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Of interest, these studies illustrate that in order to create the cell-cell contacts required 
by an epithelium, individual epithelial cells must utilize the exact same intracellular 
signaling mechanisms and cell-shape changes characteristic of motility and migration, as 
will be discussed in further detail below.  
The mechanism of cell-cell adhesion that characterizes the formation of a 
mammalian epithelium has been investigated in-vitro using mouse epidermal cells and 
canine and marsupial kidney epithelial cells. (Vasioukhin et al. 2000) Unique 
morphological changes observed during this process were verified in in-vivo using 
mouse epidermal cells. When adjacent mouse epidermal cells were stimulated with 
calcium, they produce filopodia through actin polymerization which penetrate and 
embed within adjacent cells. At the tip of each extending filapodium are clusters of 
adhering junction (AJ) related proteins such as E-Cadherin, α,β catenins, VASP, Mena, 
vinculin and zyxin. Under low calcium conditions, neither AJ’s nor desmosomes form 
(desmosomes-less dynamic and more robust cell-cell adhesions that associate with the 
intermediate filament network). Although keratinocytes were studied primarily, kidney 
epithelial cells also displayed similar behavior. Utilizing scanning and transmission 
electron microscopy (EM), the authors noted that high calcium increased the length and 
quantity of filopodial extensions. Filopodial formation increased most robustly at 
intercellular contacts. These intercellular junction filopodia appeared to protrude into 
the neighboring cell membrane without penetrating, forming a series of interdigitating 
contact points. At the terminal end of each filopodial process AJs seemed to form, as 
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evidenced by an increase in electron density and positive staining with AJ specific 
antibodies, as well as punctate actin filament bundling. These EM visualized structures 
observed in-vitro resembled interdigitating filopodial structures seen in mouse skin 
epidermal structures in-vivo, suggesting that the in-vitro results accurately represent the 
in-vivo process.  
The authors also introduced the concept of an “adhesion zipper,” consisting of a 
two-rowed AJ puncta between nascent adhering cells (each cell contributed a single 
row) during the process of epithelial adhesion and sheet formation. (Vasioukhin et al. 
2000) Within 7 hours of calcium signal initiation, the two-rowed puncta had begun to 
merge into one. As these contact sites matured, the intercellular interface became 
highly undulated: shallow depressions in one cell were filled with extensions from the 
neighboring cell. AJs lined contact points between cells. Further along in time, 16 hours 
past the initial calcium stimulus, the offset wave-and trough interdigitation had 
flattened to create continuous contacts of alternating AJs and desmosomes and by 20 
hours they had formed a single continuous line. Although the authors reported this 
alternating pattern was often observed in-vivo, the classic structural picture of epithelia 
places desmosomes and AJs physically separated, whereby AJs are located more 
apically, forming a transcellular network of parallel bundles of actin microfilaments 
capable of transmitting force laterally, while desmosome plaques locate subjacent to the 
AJs. Considering the dynamic nature of AJs, it is possible that once cells were stably 
adhered, subsequent differentiation and maturation modified the precise location of 
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the AJs to fit the structural needs of the epithelial sheet and tissue. Nevertheless, this 
study, and others, unequivocally indicate that forming cell-cell contacts within an 
epithelium required the morphological plasticity utilized by migrating cells. (Green et al. 
2010; Vasioukhin et al. 2000) In other words, every cell that is capable of forming an 
epithelium must be capable of migration. 
In-vitro studies are the least convincing method for studying the existence of 
collective epithelial migration in living tissues. Non-mammalian models provide the 
most studied in-vivo examples of collective epithelial cell migration and corresponding 
intercellular signaling networks. The phylogenetic gap between non-mammals and 
humans limits direct application of the results gleaned from non-mammalian studies, 
but the strong genetic and physiological conservation between non-mammals and 
humans allows for their use as homologous systems for studying the cell-cell signaling 
networks within migrating epithelia in humans. (Peterson et al. 2008) One such example 
is posterior lateral line formation in zebrafish. (David et al. 2002) When fully 
differentiated, the posterior lateral line is a sensory organ that allows fish to localize 
movement in their environment. Individual organs called neuromasts, innervated by 
bipolar sensory neurons, are arranged in series along the flank of the animal. During 
development more than 100 cells directionally migrate in a cohesive unit along a 
previously deposited stromal cell derived factor 1 (SDF1) chemokine strip. Migration 
along the chemokine strip required the expression of the SDF1 receptor CXC chemokine 
receptor type 4 (CXCR4) in the migrating cells. However, not all cells need to express the 
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receptor in order for the collective to move, and individual cells that lack the receptor 
migrated normally when normal cells are present. (Haas and Gilmour 2006) As little as 4 
cells, close to the leading edge (within 20 µm), out of more than 100 needed to express 
the chemokine receptor in order for the whole collective to migrate normally. 
Furthermore, under normal conditions, the migrating collective of epithelial cells 
directed the formation and extension of the lateral line nerve, which in turn guided the 
migration of glial cell precursors. Thus, the SDF1/CXCR4 signaling system in a small 
group of epithelial cells controlled the migration of multiple cell types required to form 
the lateral line sensory organ. Indeed, CXCR4 expression in a small group of cells near 
the leading edge of the collective was able to rescue the migration of all three cell types 
(neural, glial, and epithelial). These cells did not respond to a concentration gradient of 
the chemokine, and did not migrate cell-autonomously once in the chemokine stripe. 
When the strip of SDF1 was cut short, the migrating cells made a U-turn and continued 
to deposit sensory organs along the strip but in the opposite direction. Interior cells of 
the migrating cohort exhibited lamellipodia polarized in the direction of collective 
movement. Of interest, CXCR4 deficient cells exhibit this same lamellipodia morphology 
when migrating in the interior of the collective, suggesting the lamellipodia formation is 
due to intercellular signaling rather than individual response to the chemokine.  
Discrete and restricted fibroblast growth factor (FGF) signaling from neighboring 
cells was required in order to induce differentiation and associated morphological 
changes (apical constriction and formation of rosette structures) within the migrating 
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epithelial cells. (Lecaudey et al. 2008) The migrating cells were sequentially selected to 
form neuromast epithelial mechanosensory hair cells. A fundamental question regarding 
migrating collectives is what maintains the polarity within the group and allows 
directional movement.  Wnt/β-Catenin signaling seems to be involved. (Aman and 
Piotrowski 2008) APC is a necessary component of the complex that targets β-Catenin 
for destruction in the absence of Wnt signaling. Wnt signaling is critical for stem cell 
maintenance and homeostasis in mammalian tissues. For example, Wnt is necessary for 
epithelial differentiation/progenitor homeostasis in epithelial crypts of the small 
intestine, such that disruption of Wnt signaling leads to absence of crypt progenitor 
cells. Constitutive activation of the Wnt/β-Catenin pathway is a hallmark of colon 
cancer. (Reya and Clevers 2005) In zebrafish, FGF-3/10 ligands seemed to be produced 
by leading cells in the migrating cohort which acted on the trailing cells, as FGF receptor 
activation was restricted to non-leading cells. (Aman and Piotrowski 2008) Interestingly, 
Wnt/β-Catenin activates transcription of both the FGF ligand and a membrane bound 
FGF signaling inhibitor only in the leading cells. Thus Wnt/β-Catenin induced ligand 
production in the leading cells but restricted signal transduction to the non-leading cells 
portion. Forcing Wnt/β-Catenin activation throughout the migrating epithelial cohort 
slowed migration, particularly because lagging cells seemed to migrate randomly. Thus 
Wnt/β-Catenin signaling seems to facilitate independently oriented motion, and the 
restriction of this signaling to the leading edge allowed those cells to determine the 
direction of motion. Further, FGF signaling was required in the trailing region to 
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differentiate deposited epithelial cells into the radial sensory structures of the lateral 
line organ. Additionally, FGF receptor activation produced a factor Dickkopf Wnt 
signaling pathway inhibitor (dkk) that acted to limit Wnt/β-Catenin signaling. Thus 
Wnt/β-Catenin and FGF signaling between discrete groups of cells within the migrating 
cohort acted to maintain polarity of the migrating epithelium through complex signal 
activation/inhibition.  
Tracheal branching morphogenesis in D. melanogaster provides another non-
mammalian in-vivo model of collective epithelial cell migration, and offers molecular 
mechanisms of inter-epithelial cell-cell communication and differentiation potentially 
conserved in humans. Instead of lungs, drosophila utilize a network of branched and 
interconnected epithelial lined tubules that oxygenate tissues through passive diffusion 
from a small number of external openings (spiracles). This tubular network begins as 
twenty clusters of ≈80 cells (placodes) that invaginate from the ectoderm to form a bag-
like epithelium. (Steneberg, Hemphälä, and Samakovlis 1999; Affolter and Caussinus 
2008) Tracheal placodes are determined in part by the action of two transcription 
factors trachealess and drifter/ventral veinless, which induce expression of FGF-R (FGF 
receptor) and other tracheal cell specific markers. Invagination does not occur in 
trachealess mutants.  Main branches are formed when 1-2 cells within the newly 
formed sac begin to migrate in pre-determined directions. (Sutherland, Samakovlis, and 
Krasnow 1996) A different subset of cells (stalk cells-similar to mammalian collective 
migration) remain attached to and follow the leader cells. The whole structure forms a 
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hollow tube as the leader cells intravasate into the embryo. Primary, secondary and 
terminal branches sequentially form smaller structures and at the conclusions of the 
respiratory network are specialized epithelial cells called terminal cells which send out 
hollow cytoplasmic protrusions to deliver air to specific tissues. A single ectodermal 
placode creates one arborized network of air delivery cells, and multiple arborizations 
are interconnected with specialized cells known as fusion cells to form an animal wide 
network. (Zelzer and Shilo 2000) The migration guidance cue for branch formation is 
branchless, an FGF homolog, which binds to its cognate RTK, breathless (FGF-R) on the 
migrating epithelial cells to activate the MAPK signaling cascade. (Sutherland, 
Samakovlis, and Krasnow 1996) The FGF-like ligand (referred to as FGF hereafter) is 
secreted in a spatially and temporally restricted manner, originating from epithelial and 
mesodermal cell clusters external to the invaginating sac. FGF expression immediately 
precedes formation of individual epithelial outgrowths, and as sequential outgrowths 
mature, FGF expression is turned off. The main effect of FGF is to regulate primary 
branching and migration of the tracheal system, but FGF may be involved in secondary 
and terminal branch formation as well. FGF is expressed close to positions where 
secondary branches formed and FGF mutants fail to express required factors for 
secondary and terminal branches: the transcription factors pointed and 
pruned/blistered/Dsrf which act downstream of Ras. FGFR (btl) mediated signaling is 
required for filopodia extension in migrating tracheal epithelial cells (similar to TGF-B 
effects in MEE migration discussed on page 49), as visualized using 3D reconstructions of 
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time-lapse confocal imaging of an actin-GFP marker driven by FGF-R (btl) expression. 
Genetic screens uncovered a novel cytoplasmic protein that can differentiate the 
guidance effects of FGF from the motility effects, suggesting a bifurcation in the 
downstream MAPK pathway, as mutations in this protein (stumps) cause defects in 
homing/guidance but not random motility. (Imam et al. 1999) FGF-R (btl) mutant 
experiments seem to reveal a competition within the migrating cohort for activation 
through FGF signaling, such that cells with the strongest response to FGF become leader 
cells by migrating to the leading portion of the collective. Cells with a kinase domain 
mutation within FGF-R that weakens but does not abolish responsiveness to FGF almost 
never adopted a leader cell fate. Complete loss of FGF-R activity reduced the number of 
leader cells, such that the ratio of leader cell to stalk cell was altered from 1:3 to 1:51. 
Thus it seems in the selection of cells for leader cell fate, there is a competition amongst 
the invaginated tracheal cell pool. Cells with greater responsiveness to a guidance cue 
can even change position within the adhered migrating cohort and navigate to the lead, 
perhaps with cooperation from the other cells in the cohort. Once leader position is 
established, lateral inhibition through production of the Notch ligand Delta and 
subsequent Notch activation in neighboring cells seems to limit the number of leader 
cells that are formed, presumably in order to maintain coherent migration. (Ghabrial 
and Krasnow 2006) This restriction of leader cell differentiation, through lateral 
inhibition of FGF-R by Notch in D. melanogaster is similar to the dkk mediated inhibition 
of Wnt/B-catenin signaling in zebrafish. 
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Individual tracheal branches require inputs beyond FGF in order to differentiate 
properly. A member of the TGF-β superfamily, dpp is required for dorsal branch 
formation (a primary branch). Dpp controls both the number of migrating cells in the 
dorsal branch and the differentiation of the specialized doughnut-like fusion cell that 
mediates the formation of connecting junctions between arborized placodes within the 
animal. The fusion cell is identified by expression of the Zn-finger protein escargot. One 
effect of dpp signaling in the selection and differentiation of the fusion cell is the 
induction of Delta expression. Escargot led to expression of the cell-cell adhesion 
protein E-Cadherin in the fusion cell while reductions in dpp signaling prevented the 
fusion cell from adhering to its cognate partner. (Zelzer and Shilo 2000) A series of 
imaging experiments utilizing ectopic expression revealed that Delta expression from 
the fusion cell activated Notch signaling in surrounding cells to restrict their fate away 
from a fusion cell, in an identical mechanism as leader cells restricted the fate of 
neighboring cells to stalk cells in both zebrafish and D. melanogaster. (Steneberg, 
Hemphälä, and Samakovlis 1999) FGF signaling was shown to induce Delta expression, 
and although all tracheal cells expressed FGF-R, Notch activation in cells outside of the 
migrating tip cells restricted MAPK activation downstream of FGF to the tip cells only, 
thereby selecting FGF signaling in a subgroup of tracheal cells to promote motility and 
coordinate guidance of the entire group. (Ikeya and Hayashi 1999) 
Continuing with a discussion of receptor tyrosine kinases, and revealing further 
complicating factors of signaling cascades, the RTK EGFR is known to control cell 
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proliferation, survival and differentiation in multiple different tissues and species. (Shilo 
2005) In drosophila EGFR primarily signals through the Ras1/Raf/MEK/MAPK (ERK1/2) 
pathway, and controls the ultimate lineage determination of multiple cell types. 
Modulation of the pathway seems to occur through alternate mechanisms besides 
ligand binding and a number of mechanisms have been identified. The principle ligand 
of EGFR is Spitz, which is expressed in membrane-bound form and is only able to 
activate its receptor upon proteolytic cleavage, similar to Notch. Spitz appears to be 
most similar to TGF-β in structure, but possesses functional EGF domains and signals 
through EGFR. Second, a multi-pass transmembrane protein Rhomboid (perhaps the 
Spitz protease) seems to potentiate EGFR signaling, and its expression is regulated more 
stringently than the EGF receptor or ligand. Additional ligands exist for EGF-R that also 
show a more restricted expression pattern than Spitz, such as vein and gurken. As a 
further modulatory mechanism, there exists a secreted EGFR inhibitor, Argos, which 
does not interact with the EGF receptor but rather sequesters and inactivates its ligand 
in the extracellular space. (Klein et al. 2004) Of interest, Argos is produced in cells with 
high levels of EGFR activation, and is thought to inhibit Ras1/Raf/MEK/MAPK (ERK1/2) in 
neighboring cells, thereby restricting ERK1/2 activation to the leading cells. (Wasserman 
and Freeman 1997) Interestingly, Argos seems to diffuse faster than spitz despite being 
physically larger, suggesting Argos activity requires inter-epithelial cooperation.  
As a confirmation of this pathway’s relevance to human diseases, ERK1/2 is 
known to drive coordinated epithelial migration during wound healing in mammalian 
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cells (reviewed in an earlier section of this review). Lastly, genetic screens identified an 
intracellular inhibitory factor for Ras1-MAPK (ERK1/2) named sprouty, from the 
observation that its knockout caused excess tracheal branching. Loss of function 
mutants for sprouty also exhibit excessive accumulation of photoreceptor and pigment 
epithelial cells in the developing eye, suggesting sprouty limits cell accumulation or 
migration. Sprouty is associated with the intracellular membrane and seems to interact 
with multiple RTKs (FGF, EGF, Torso, Sevenless). It immunoprecipitates with Drk 
(downstream of receptor kinase), a homolog of mammalian Grb2, and GTPase activated 
protein 1 (Gap1). Drk and Gap1 are signal adaptors between the EGF receptor and Ras1. 
(Casci, Vinós, and Freeman 1999) Mammalian homologs to sprouty which are amenable 
to drug-induced activation (or disinhibition if endogenous inhibitors are found) could 
have utility for restricting RTK activation and limiting migration in cancerous cells.  
Four homologs of sprouty (1-4) have been identified in mammalian systems. 
They have been shown to antagonize RTK mediated Ras signaling from a wide range of 
receptors: EGFR, FGF-R, vascular endothelial growth factor (VEGF-R), platelet derived 
growth factor (PDGF), nerve growth factor (NGF), brain derived neurotrophic factor 
(BDNF), glial derived neurotrophic factor (GDNF) and hepatocyte growth factor receptor 
(c-MET). In the failing mammalian heart, sprouty1 is downregulated in cardiac 
fibroblasts through increased expression of the sprouty1 targeting microRNA miR-21. 
Thus miR-21 seems to activate the Ras1-MAPK (ERK1/2) pathway in the face of local 
tissue inhibition, promoting the survival of fibroblasts. Increased fibroblast survival leads 
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to enhanced fibrosis and architectural support for the poorly performing heart. 
However, modern cardiac care has circumvented the need for this endogenous but 
imperfect fibrotic protective mechanism. To this end, the authors found inhibiting miR-
21 reduced Ras1-MAPK (ERK1/2) signaling, reducing fibrosis and hypertrophy while 
normalizing contractility. (Thum et al. 2008)  In another study, sprouty2 overexpression 
reduced tumor frequency by nearly 30%, and tumor volume by 40%. (Minowada and 
Miller 2009) Thus sprouty proteins are plausible targets to retard Ras1-MAPK (ERK1/2)  
overactivation and the excessive cell accumulation and migration in tumorigenesis. 
 
Questions regarding the Epithelial to Mesenchymal Transition  
Epithelial migration during development and metastasis was previously thought 
to require a dramatic transdifferentiation of an epithelial cell into an entirely different 
state: the epithelial to mesenchymal transition (EMT). (Kalluri and Weinberg 2009) 
However, a critical review of the supporting data suggests that this transdifferentiation 
program is an in-vitro artifact rather than a physiological reality. The in-vitro studies that 
supported this theory lacked the differentiating and inhibitory pressures supplied by 
tissues in-vivo. Well-studied examples of collective epithelial migration during 
developmental or physiological processes (wound healing, MES, drosophila trachea and 
zebrafish lateral line formation described above) are conserved across evolution. 
Furthermore, utilizing both clinical data and animal models, it will be proposed that 
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collective migration is the main mechanism by which epithelial cells metastasize, 
obviating the need for an EMT program.  
Confusion regarding the prevalence of EMT will be discussed, starting with a 
proposed EMT marker snail. The snail family of transcriptional repressors (mentioned 
previously during the discussion of Elf5) have defined functions in cell-survival and 
motility, but are also expressed in cases of collective or adhered migration where 
epithelial morphology is maintained, and therefore cannot be a true marker of EMT. 
Nevertheless, snail expression has been firmly linked to EMT. (Wang et al. 2013) 
Historically the role of the snail superfamily was thought to be restricted to mesodermal 
development and the induction of motility, and only later were its capabilities stretched 
to also define EMT. EMT is amorphously defined as the process by which differentiated 
epithelial cells lose neighboring cell-cell contacts and adopt a mesenchymal and 
migratory phenotype and morphology similar to fibroblasts (spindle-like with cellular 
processes). The EMT transitioned cell is thought to disseminate from its previous 
residence in a stationary epithelium using individual migration. This process has been 
accepted as dogma in development and metastasis, yet it deserves a critical review. 
(Thiery et al. 2009) EMT induction is purportedly initiated by receptor tyrosine kinase 
activation, through such ligands as EGF, hepatocyte growth factor (HGF), FGF, TGF-β and 
bone morphogenic protein (BMP). (Barrallo-Gimeno and Nieto 2005; Nieto 2002) In the 
context of carcinogenesis, it was thought that E-Cadherin was downregulated in invasive 
carcinomas, and snail was identified as a transcriptional regulator of E-Cadherin. (Perl et 
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al. 1998) This snail/E-Cadherin relationship alongside the notion that snail’s broader 
function was to induce EMT led to the idea that EMT was the ultimate regulator and 
initiator of the metastatic cascade. So widespread was the idea that an EMT transition 
was required for successful metastasis, that in the 2011 reboot of the supremely 
influential Hallmarks of Cancer, EMT was reported to “Broadly regulate invasion…” and 
be the mechanism by which transformed epithelial cells became invasive. (Douglas 
Hanahan and Weinberg 2011) However, as outlined in a thoughtful review by Barrallo-
Gimeno and Nieto, snail may be implicated in all studied EMT processes, but that does 
not mean the role of snail is to induce EMT. (Barrallo-Gimeno and Nieto 2005) In the 
following example regarding the development of the mammalian hard palate 
epithelium, long-range migration and snail activation will be shown to occur without 
loss of epithelial identity. 
Palatal Shelves in mammals migrate as an adhered epithelial unit, the so called 
median edge epithelium (MEE). Eventually the leading edge cells (similar to tip cells) 
from opposing right and left migrating units adhere to form a thickened midline 
epithelial seam (MES). When these two groups of migrating epithelia come together, 
the leading cells intercalate and bind firmly using filopodia and lamellipodia, again 
suggesting the formation of a coherent epithelium required morphological changes 
characteristic of migration. Snail is expressed at the cells of the leading edge despite 
their firm adherence to neighboring epithelial cells located laterally and to the rear. 
TGF-B3 signaling from the mesenchyme is crucial for palatal fusion and filopodia 
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formation and is thought to act upstream of snail. Without TGF-B3, soon-to-be adhered 
MEE cells have dramatically reduced filopodia on their apical membrane, but maintain 
strong E-Cadherin expression at their basal surface. Snail1 and snail2 null animals show 
defects in MEE migration, but exhibit ample filopodial formation. (Murray, Oram, and 
Gridley 2007) TGF-B3 null mice maintain snail expression, perhaps through overlapping 
roles of related TGF-B family members. Mesenchymal sources of TGF-B1 upregulate 
expression in the absence of TGF-B3. TGF-B3 null mice do have defects in MEE filopodial 
formation and cell-cell intercalation but migrate normally. Thus it seems there are 
different roles for snail family members and TGF-B3 in palatal shelf fusion, whereby 
snail regulates migration and TGF-B3 regulates formation of the filopodia necessary for 
the adhesion of the migrating shelves once they come in contact. (Taya, O’Kane, and 
Ferguson 1999; Martínez-Alvarez et al. 2004) Without MES epithelium fusion, the nasal 
and oral cavities do not separate, resulting in a so-called cleft palate. (Martínez-Alvarez 
et al. 2004; Barrallo-Gimeno and Nieto 2005) This provides an example of collective 
epithelial cell migration in development where a “marker” of EMT is expressed without 
the loss of intercellular adhesion. It also questions the tightly held assertion that EMT is 
required for epithelial cell migration in development. (Thiery et al. 2009; Kalluri and 
Weinberg 2009)  
The snail family member slug shows increased expression without induction of a 
mesenchymal phenotype in cutaneous wound healing. As reviewed above, migrating 
mammalian keratinocytes retain cell-cell junctions and move as a cohesive sheet during 
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re-epithelialization in response to tissue injury. Slug was expressed in leading edge cells 
as they migrated over the wound area, even as these cells maintained contact with the 
sheet of epithelial cells. (Savagner et al. 2005)Inhibiting cell division and DNA synthesis 
with mitomycin-C did not change the wound re-epithelialization process, suggesting that 
slug expression at the wound margins was associated with migration without 
proliferation. 
One might argue that, in the discussion of the functions of snail family member 
genes, the role of EMT transitions are overstated. As outlined above, there are multiple 
examples snail family expression in the context of motility with retained epithelial 
integrity. A close reading of the EMT literature reveals that the phenomenon would be 
more aptly named “collective epithelial migratory phenotype.” In opposition to the SMT 
theory, mounting evidence suggests the epithelial cell is a morphologically plastic cell 
with an inherent ability to migrate in groups. Rather than a default state characterized 
by senescence, differentiation and inhibition of motility, these are phenotypes imposed 
by signals from the environment. Reversion to a motile state is an expression of an 
innate characteristic, not the acquisition of a new ability. It follows that this program 
must come from a removal of differentiating factors, rather than the addition of an EMT 
inducer or genetic mutation.  
The confusion regarding the EMT transition is easy to understand given the 
experimental conditions used to generate the observation. Induction of migratory 
behavior from individual epithelial cells is readily observable under in-vitro culture 
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conditions. (Casas et al. 2011) Data rigorously presented by Hay in the 1960s-2000s 
using this type of experiment supported the concept of EMT. Importantly, EMT has 
always lacked strong support from in-vivo data. (Greenburg and Hay 1988; Greenburg 
and Hay 1986) Interestingly, a closer review of the gastrulation/mesodermal invasion 
studies performed in the 1980’s readily admit that single-cell movements were rare, and 
instead movement with retained cell-cell contacts was seen much more often. 
(Nakatsuji, Snow, and Wylie 1986) If we admit the possibility that the specialized 
morphology of a fully differentiated epithelium is exogenously imposed rather than 
generated by individual cells through genetic pre-determination, the observation that 
epithelial cells acquire motility in-vitro is not surprising. Furthermore, not only do 
culture conditions remove inhibitory signals, they also supply activating signals. In-vitro 
studies developed by Hay to link EMT to development or more recently performed by 
Weinberg’s group to link EMT to the metastatic process utilize a wholly unnatural 
microenvironment in part through growth factor enrichment. (Greenburg and Hay 1986; 
Yang et al. 2004) Analysis of calf serum similar to that utilized by both groups include 
bFGF, TGF-β1, IGF and glial growth factor (GGF) among others. (Zheng et al. 2006) Given 
that a tissue-imposed epithelial phenotype is a possibility, it follows that the 
microenvironment could severely regulate the availability of nutrients and other 
signaling pathways activators, a situation wholly unlike in-vitro conditions which provide 
nutrients in overabundance and lack differentiating pressures. For these reasons, it can 
be argued that conclusions drawn from in-vitro studies have less relevance to the 
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understanding of tumor progression in-vivo than what is commonly assumed. In-vitro 
studies have yielded a wealth of information on signaling cascades and the biology of 
individual cells, but very likely miss key events in the complete pathway of 
carcinogenesis.  
 
What Does Metastasis Look Like in the Clinic (in-vivo)? 
A good place to truly examine the relevance of EMT, and investigate how cells 
actually migrate in cancer is through examination of human tissue samples. Is there 
abundant clinical evidence to indicate that EMT is part of the metastatic cascade, as a 
majority of the cancer biology field would argue? (Douglas Hanahan and Weinberg 
2011) A recent review admitted the lack of evidence for a binary switch during EMT 
transition and indicated that epithelial markers were retained in these supposedly 
“mesenchymal” cells. (Ye and Weinberg 2015) Furthermore, data on which they base 
their argument only utilized “markers” of mesenchymal cells without much 
consideration of actual cell morphology. Their “rigorous” criteria for EMT existence in an 
in-vivo model of pancreatic ductal carcinoma (overexpressing Ras and lacking p53) 
included one cell showing both mesenchymal and epithelial markers in less than 5% of 
the induced pre-malignant lesions. (Rhim et al. 2012) Furthermore, the cells they chose 
to best illustrate this process in their report (i.e. used in figures) were clearly not 
migrating as individuals, but were instead closely associated and in contact with their 
neighbors.  
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Nonetheless, does a comprehensive histological analysis of clinical samples 
confirm the existence of EMT? Noted pathologist David Tarin has studied many 
thousands of patient tissue samples without observing a single convincing EMT 
occurrence. He believes the existence of poor and disordered differentiation 
characteristic of carcinomas fools researchers into believing in the existence of EMT. But 
he affirms that such morphological disorder does not call for invoking the drastic change 
in cell lineage necessitated by an EMT transition. As an example, infiltrating lobular 
carcinomas of the breast do not migrate as scattered individual cells, but rather in a 
sequential daisy chain, firmly adhered to their front and back neighbors, reminiscent of 
collective epithelial cell migration utilized during development in mammalian and non-
mammalian systems. Certainly the polarity of these cells has changed, and they have re-
expressed migratory characteristics, but they have not lost their epithelial identity. 
Furthermore, adenocarcinomas invade as glandular structures, and squamous cell 
carcinomas invade as clumps and maintain differentiation and the phenotype of 
secretory epithelium, even producing keratin. Even the occasional spindle cell 
appearance of squamous and adenocarcinomas are rarely seen migrating individually. 
(Tarin 2005) Furthermore, these cells are most likely myoepithelial cell in origin rather 
than the result of a dramatic transdifferentiation program into an entirely different cell 
lineages. (Zarbo 2002; Tarin 2005) At some point after arrival at the metastatic niche 
site, these cells should finish their differentiation program and adopt a fully 
mesenchymal identity, such as adipose tissue, muscle or bone. Yet this scenario is not 
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observed clinically. Instead the origin of distant metastatic sites is commonly identified 
by the metastasizing cells consistency with features from the original neoplasm, arguing 
that these cells never lost their identity in the first place.  (Tarin 2005) Thus EMT theory 
seems to indicate that cancer cells change their gene expression pattern to become an 
different cell type, and is able to run this program in reverse at the new metastatic 
niche. Differentiation cues at that distant niche presumably would drive the newly 
mesenchymal cell to form structures supporting the new tissues, rather than the site of 
origin. That differentiating signal at the metastatic niche presumably would be ignored 
while other signals are integrated, so as to allow expression of integrins corresponding 
to the new ECM for example. Thus the cancer cell must ignore the strong cues to 
differentiate into a functionally useful cell for tissue, but “listen” to the cues that 
recognize that they have in fact arrived to a suitable niche.  
 Clinically many examples exist of metastatic and invasive carcinomas retaining a 
well-differentiated epithelial morphology, indicating EMT is not required for metastasis. 
Prostate metastatic lesions in lymph nodes retain epithelial features and a polarity 
characteristic of prostate epithelium. They form acinar glandular structures with normal 
apical/basolateral polarity. Their secretory phenotype is recognizable; nuclei are located 
in the basolateral portion of the cell while secretory products were confined to the 
apical portion. Apical specific markers were retained in their usual polarized location. 
(Christiansen et al. 2005) Furthermore, in a study of 149 patient samples of invasive 
ductal breast carcinomas, less than 10% of the invasive tumors did not form 
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recognizable epithelial tubules and most cells were polarized normally. (Tan et al. 1999) 
An additional study of 208 tumor biopsy samples found 72% stained positive for E-
Cadherin, a marker of cell-cell contact. The expression of this adhesion marker was 
unrelated to invasion of lymph nodes or appearance of other metastatic lesions. 
(Lipponen et al. 1994) Further, elegant 3D reconstruction of tumor buds at the invasive 
fronts of adenocarcinoma tumors, where cancer cells are exiting the main tumor and 
entering the stroma, in the lung, pancreas, colon and beast revealed it was extremely 
unlikely to have a single cell invading the stroma. Their analysis of 5000 invasive buds 
across 15 tumor samples indicated the chance of finding a single invasive cancer cell was 
.003%, at 99.9% statistical power. Instead most buds were multi-cellular and retained 
connection to the primary tumor. (Bronsert et al. 2014) These data give further 
evidence that metastasis occurs without the need to invoke a radical change in cell 
lineage. They reveal that infiltrating epithelial cancer cells migrate adhered to one other 
while retaining much of their original morphology. It also indicates that we should 
explore collective cell migration in greater detail, utilizing progress made in mammalian 
and non-mammalian models discussed above, if we aim to dissect the true program of 
metastatic progression. We have been easily led astray when trying to answer in-vivo 
questions using in-vitro artificial environments. If instead we ground our observations 
on clinical data that reveal epithelial features are retained within invading groups of 
cells, it becomes unnecessary to invoke a radical change in gene expression and lineage 
in order to explain the “acquired” motility of epithelial cells. Single cell “mesenchymal” 
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migration, so beautifully described in 2D collagen preparations, does not accurately 
recapitulate the nature of metastasis in-vivo. If we accept that epithelial cells can both 
be motile and maintain cell-cell adhesions, then the process of unraveling the 
mechanisms of invasion will be greatly simplified.  
Further evidence that the re-expression of a motile phenotype in epithelial cells 
does not require a dramatic and global change in gene expression comes from the fact 
that nearly every stimulus (even non-mutagenic) can induce “EMT.” Almost all peptide 
growth factors (EGF, HGF, TGF-β), cytokines, transcription factors, hypoxia, oxidative or 
metabolic stress, or collagen sheets can induce EMT. (Savagner 2015) It seems as soon 
as an epithelial cell is placed in-vitro, thereby removing the microenvironmental factors 
maintaining its differentiation, any stimulus can induce motility. This bolsters the idea 
that migration is an endowed capability rather than acquired one in epithelial cell types. 
 
 
Cell-Cell Cooperativity of Heterogeneous Cell Populations Facilitate Metastatic 
Invasion  
 
Migratory macrophages and eosinophils seem to play a role in development of 
the mammary gland. (Gouon-Evans, Rothenberg, and Pollard 2000) Both cells 
preferentially accumulate near terminal end buds, the mitotically active migratory 
glandular structures that serve as precursors for ductal development. Depleting 
leukocytes through sublethal γ-irradiation inhibited ductal outgrowths, without affecting 
proliferation of mammary epithelial or stromal cells, or increasing estrogen levels (the 
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major hormone for mammary gland development). Bone marrow transplant 
immediately after irradiation rescued ductal development, and this rescue coincided 
with the re-emergence of leukocytes in the blood and accumulation of macrophages 
and eosinophils at terminal end buds. Mice deficient in the macrophage differentiating 
factor colony stimulating factor 1 (CSF1) are depleted of macrophages. These transgenic 
animals exhibit disorganized and under-developed mammary gland ductal trees. This 
phenotype was completely rescued upon exogenous CSF1 supplementation.  
 In a murine model of breast cancer, macrophage depletion through CSF1 
knockout significantly delayed and reduced lung metastasis, but did not alter primary 
tumor growth. Correspondingly, loss of macrophages also retarded tumor histological 
progression to late-stage invasive carcinoma. Tumor advancement to the invasive stage 
was correlated with macrophage infiltration to the tumor site. However, in the CSF1 null 
mutants, although tumors took a significantly longer time to progress to the invasive 
carcinoma stage, they did ultimately show a metastatic phenotype without peritumoral 
macrophage accumulation. Yet CSF1 overexpression in the mammary epithelium 
significantly advanced tumor progression to the invasive stage, suggesting macrophages 
promote tumor progression but has functional redundancies. (Lin et al. 2001) The 
mechanism of this macrophages and tumor cell interaction has been proposed to be a 
paracrine signaling loop, whereby cancer cells release the macrophage attractant CSF1, 
while in turn macrophages secrete EGF which activates the tumor cell. This signaling 
mechanism may create a positive feedback loop, as CSF1 binding on macrophages led to 
58 
increased production of EGF, and EGF binding on carcinoma cells promoted CSF1 
production. These two cell types were observed to migrate together toward an artificial 
chemotactic gradient and inhibition of either CSF1 or EGF signaling was able to block 
migration of both cells in-vitro. (Goswami et al. 2005)  
Macrophages are thought to accumulate specifically at the tumor margin and 
along the tumor vasculature. Metastasizing tumor cells are observed to preferentially 
intravasate into vessels near perivascular macrophages. CSF1 depletion, confirmed by a 
6-fold reduction of perivascular macrophages, led to a 16-fold reduction in viable tumor 
cells in the systemic circulation. Intravenous injection of anti-CSF1 antibody reduced 
tumor cell levels in blood by 6-fold, suggesting this process is CSF1 dependent. (Wyckoff 
et al. 2007) Although no mechanism was suggested by which the macrophages signal 
endothelial cells to improve cancer cell dissemination efficiency, these data suggesting 
that perivascular macrophages do aid in the vascular intravasation of disseminating 
tumor cells.  
 Fibroblasts may play an integral role in cancer cell dissemination. Fibroblasts are 
endogenously capable of modifying the ECM, which metastasizing epithelial cells must 
navigate en route the vasculature. A fascinating study using a modified culture system to 
recapitulate in-vivo conditions in-vitro has shown that fibroblasts may lead groups of 
collectively migrating squamous carcinoma cells (SCC), a phenomenon that has also 
been identified in subsequent studies using adenoid cystic carcinoma (ACC) cells and 
cancer associated fibroblasts (CAFs) derived from the salivary gland. (Li et al. 2016) 
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When SCC epithelial cells were cultured alone upon a dense matrix consisting of 
predominantly collagen I, with a lesser density of laminins and collagen IV, they did not 
invade. But if fibroblasts isolated from either oral or vulval squamous cell carcinoma 
were mixed into the underlying matrix, the overlaid SCC cells invaded the matrix as 
adhered cohorts of cells, while maintaining expression of the epithelial markers E-
Cadherin and p120 catenin. Interestingly, the migration speed of SCC epithelial cells was 
not significantly enhanced by the presence of fibroblasts, confirming that cohorts of 
epithelial cells were capable of collective invasion autonomously. Adding an 80 µm layer 
of matrix between the SCC cells and the fibroblasts abolished SCC invasion into the 
matrix, suggesting that it was not a long range diffusible factor secreted by the 
fibroblasts that promoted invasion. However, if the underlying matrix was first cultured 
with fibroblasts, then fibroblasts depleted, SCC cells were able to invade. This, along 
with co-culture barrier experiments, suggested it was fibroblasts-mediated remodeling 
of the matrix that permitted the SCC invasion rather than intercellular signaling. 
(Gaggioli et al. 2007) Although the presence of a short range signaling factor could not 
be ruled out. Another group found fibroblast mediated remodeling and alignment of 
collagen fibers at the tumor/stromal junction, elegantly detected by plane-polarized 
imaging, as well the fact that cancer cell migration velocity and directional coordination 
increased over this area of modified ECM. (Lee et al. 2011) However, in the enhanced in-
vitro co-culture study using SCC cells, the most successful invasion occurred when 
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fibroblasts and SCC cells were first mixed then deposited on top of the matrix together, 
suggesting the fibroblasts acted in an manner beyond ECM modification.  
Closer analysis of invading chains of epithelial cells revealed that fibroblasts 
always led the invading epithelial cohort, although subsequent epithelial cells were able 
to change position within the migrating cohort, as noted in other studies. It was not 
investigated whether this reorganization depended on intracellular signaling strength, 
akin to what is observed in drosophila tracheal cell migration. Transmission electron 
microscopy revealed the presence of holes in the matrix behind migrating fibroblasts, 
and SCC cells within these holes. The remodeled matrix behind fibroblasts consisted of 
thickened bundles of collagen along the sides of the formed tubes, and deposition of 
ECM components fibronectin and tenascin C, although inhibition of fibronectin and 
tenascin C deposition did not alter SCC invasion. Further analysis of the fibroblast 
migration revealed a dependence on Rho/ROCK signaling. Blockade of RhoA (but not 
RhoB), ROCK1 or ROCK2 inhibited the formation of holes and the ability of fibroblasts to 
contract matrix.  Blocking non-muscle myosin, ECM interacting Integrin α3 or α5 or MMP 
function also inhibited fibroblast dependent matrix remodeling and subsequent SCC cell 
invasion. Only one downstream target of ROCK was correlated with the ECM remodeling 
ability of fibroblasts, the phosphorylation of myosin light chain. Interestingly, inhibition 
of Rho, ROCK or Integrin α3 or α5 function in SCC cells did not affect their invasive 
ability, suggesting they used alternate signaling pathways than the fibroblasts to 
generate motility in this assay. Indeed, inhibition of cdc42 (akin to mammalian epithelial 
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migration during wound healing) and myotonic dystrophy kinase-related CDC42-binding 
protein kinases (MRCK) in SCC cells abolished their ability to follow fibroblasts, and 
disrupted co-localization of phosphorylated myosin light chain at the actin cortex in 
these cells. Further, histological analysis of clinical tissue samples of head and neck 
squamous cell carcinoma revealed fibroblast led collective invasion of SCC cells, and 
activation of Rho within the fibroblasts. (Gaggioli et al. 2007) This work was bolstered by 
the observation that collagen fibers surrounding human tumors were reorganized to 
align normal to the tumor/stromal interface, similar to what was seen in the model, and 
this seemed to enhance cancer cell dissemination from the tumor site. (Provenzano et 
al. 2006) 
 The data regarding separate intracellular mechanisms of cell-shape change and 
migration within the fibroblasts and SCC cells is interesting. Other studies have indicated 
that ROCK and MRCK signaling cooperate to mediate actinomyosin contractility, as they 
both ultimately modulate myosin light chain 2 (MLC2) phosphorylation through T696 
phosphorylation on MYPT1 (myosin phosphatase target subunit 1), upstream of MLC2. It 
seemed ROCK and MRCK function could overlap during an in-vitro invasion study using 
colorectal carcinoma cells. Both ROCK and MRCK mediated morphological modifications 
of BE cells into a rounded (more dependent on ROCK) or elongated form, either of which 
could be used to drive motility. (Wilkinson, Paterson, and Marshall 2005) Identification 
of overlapping pathways of motility is vital, at least in CAFs as a study on a limited 
number of cancer cell types has shown that CAFs (and less convincingly, the epithelial 
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MDA-MB231 cell line) could modify their method of motility when their “preferred” 
method was blocked. In a fibrosarcoma cell line which usually migrated in a protease 
dependent mechanism and maintained a spindle-like morphology, Integrins and MMPs 
co-localized at the cell membrane which allowed adherence to and degradation of the 
matrix. However, when this method of migration was blocked using a protease cocktail, 
the cells adopted a more rounded, “amoeboid” morphology, but did not change overall 
migration speed. (Wolf et al. 2003) 
 Another study sought to investigate the signaling cascades by which normal 
fibroblasts conferred the pro-invasive CAF phenotype. TGF-B1 treatment was sufficient 
to convert dermal fibroblasts, who had previously been unable to facilitate SCC12 
invasion nor contract collagen gels, into a phenotype that could promote invasion of 
these activated epithelial cells. Interestingly while TGF-B1 was found necessary to 
promote CAF conversion, while Janus kinase/signal transducer and activator of 
transcription (JAK/STAT3) was required to maintain the CAF phenotype. Further 
investigation revealed that TGF-B1 mediated a 100-fold increase in the expression of the 
cytokine leukemia inhibitory factor (LIF) and a 5-fold increase in mRNA of the interleukin 
6 (IL-6) cytokine. Together these cytokines appear to mediate STAT3 phosphorylation 
and activation downstream of JAK1. As confirmation, LIF blocking antibodies abrogated 
the ability of TGF-B1 to induce collagen gel contraction by fibroblasts and promote 
SCC12 cell invasion. Furthermore, fibroblasts treated with LIF alone were able to 
recapitulate the TGF-B1 actions to promote the CAF phenotype. SiRNA mediated 
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knockdown of RhoA or blockade of ROCK was able to abolish both TGF-B1 and LIF 
mediated effects. Taken together, the results show that the LIF cytokine is actually 
responsible for TGF-B1 induced actinomyosin activation and contractility underlying the 
ECM remodeling by fibroblasts used to enhance epithelial cancer cell invasion. 
Furthermore, media conditioned by two related SCC cell lines was able to transform WT 
dermal fibroblasts into CAFs. Only antibody blockade of LIF, not TGF-B1, was able to 
stop this transformation. This gives a mechanism by which carcinoma cells could induce 
CAF formation in the tumor microenvironment, and also reveals the dependence of this 
process on LIF rather than TGF-B1, which shows ubiquitous signaling molecules may 
have more specific mediators downstream outside of their signaling cascade. This 
process was also revealed to be independent of TGF-B1 induced α-SMA expression. This 
is an important point, as CAFs are traditionally defined by α-SMA expression, yet this 
study revealed that LIF stimulated fibroblasts can promote invasion of carcinoma cells 
without expressing α-SMA as commonly assumed. (Albrengues et al. 2014; Kalluri and 
Zeisberg 2006)  
 To investigate further in-vivo, two breast carcinoma cell lines that dramatically 
differed in their LIF expression were transplanted into fat pads of mice. Peritumoral 
collagen fibers were remodeled and aligned in the tumors produced by high LIF 
producing cells. Inhibiting JAK1/2 with Ruxolitinib abolished STAT3 activation, collagen 
fiber realignment, and also significantly reduced tumor cell invasion into the stroma, but 
did not change the tumor size. Furthermore, Ruxolitinib treatment abolished the ability 
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of activated fibroblasts (CAFs) treated with LIF or TGFB1 to promote invasion of 
squamous carcinoma cells, contract collagen gels or realign collagen fibers. LIF staining 
was high in biopsies from lung, skin and head and neck carcinoma samples. Further 
analysis of these carcinoma types revealed that collagen reorganization and alignment, 
and worse clinical outcomes were associated in carcinomas of relatively high LIF 
expression. (Albrengues et al. 2014) LIF inhibition therefore could be an attractive target 
to reduce cancer cell metastasis. 
A hallmark of the tumor microenvironment is angiogenesis. A de-novo 
vasculature is required to nourish a growing tumor mass, and tumors without 
angiogenesis show increased cancer cell apoptosis or necrosis prohibiting additional 
tumor growth. Further, the ability of cancer cells to metastasize to distant sites is 
enhanced by the additional routes created by new vessels to access the systemic 
circulation. Vascularization is stimulated by the VEGF family of polypeptides, originally 
identified by Harold Dvorak as factors promoting vascular permeability secreted by 
cancer cells. Separately VEGF was identified by other groups studying angiogenic FGF 
signaling initiated by Judah Folkman’s work on cancer cells. (Douglas Hanahan and 
Weinberg 2008; Senger et al. 1986; Senger et al. 1983) VEGF-C is thought to contribute 
to angiogenesis in the tumor microenvironment by binding VEGF-R3 expressed on 
migrating endothelial tip cells at the leading edge of growing vessels. (Baeriswyl and 
Christofori 2009) VEGF induced filopodia formation in endothelial tip cells. Tip cells 
migrate with stalk cells as part of an adhered endothelial collective toward VEGF 
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gradients, similar to tip/stalk cell behavior in response to FGF in the developing trachea 
in D. melanogaster, or Wnt/β-Catenin in zebrafish (Gerhardt et al. 2003) Notch signaling 
between tip and stalk endothelial cells further recapitulates D. melanogaster trachea 
development, whereby lateral inhibition through Notch receptor activation restricts 
cells away from a tip cell fate. Heterozygous dll4 (delta like ligand for Notch) null mutant 
mice display increased filopodia formation and an increased number of tip cells, while, 
Lox/Cre inactivation of Notch1 selectively produces tip cells. Nearly all tip cells showed 
dll4 expression, akin with tip cell production of similar Notch ligands in D. melanogaster. 
(Hellström et al. 2007) Further, just as FGF induces dll expression in D. melanogaster tip 
cells, VEGF-A induces dll4 expression in endothelial cells, most appreciably at the leading 
front of vascular sprouts (the tip cell region). (Lobov et al. 2007; Hainaud et al. 2006) 
Exogenous Notch activation, using the Notch signaling peptide jagged1, decreased 
filopodial density by one third, decreased vessel density by nearly half and significantly 
reduced branching. (Hellström et al. 2007) In terms of cancer therapy, targeted 
activation of Notch signaling, restricted to endothelial cells using an ADC (Antibody-Drug 
Conjugate) or similar targeted drug delivery system, would be an intuitive mechanism to 
disrupt tumor vasculogenesis. It would reduce lamellipodia formation, vessel sprouting, 
and branching to limit the ability of the de-novo vascular tree to supply nutrients for 
tumor growth.  
Curiously the reverse strategy has moved into the clinic as a potential cancer 
therapy. Inhibitors of Notch signaling, such as GSIs (γ-secretase inhibitors), or antibodies 
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against the notch ligand dll4, are currently being tested in clinical trials. (Khan and 
Bicknell 2016) The rationale is that Notch inactivation would lead to inappropriate and 
excessive tip cell formation and overabundant branching thereby reducing the perfusion 
efficiency of the newly formed vessels. Unfortunately, intestinal toxicity has been 
associated with GSIs. GSI treatment led to excessive production of secretory cells and a 
relative paucity of absorptive cells in the intestine, as Notch signaling cooperates with 
Wnt/β-Catenin direct differentiation in the intestinal crypt.  
Some investigators have utilized Notch inhibition to drive differentiation 
programs thereby slowing tumor growth and inhibiting tumor mitosis. They have noted 
that APC null proliferative adenoma cancer cells are converted to post-mitotic goblet 
cells upon Notch inhibition, providing a viable treatment option if gastrointestinal side 
effects could be reduced. (van Es et al. 2005) In fact, selective targeting of individual 
Notch receptor subtypes (e.g. Notch1 selective) has shown potent anti-tumor and anti-
angiogenic effects while eliminating the over-representation of secretory cell types in 
the intestine, thereby potently reducing or eliminating intestinal toxicity. (Wu et al. 
2010) 
Modulating Notch signaling may provide a powerful method to disrupt the 
migration of groups of epithelial and endothelial cells. This in turn could profoundly 
impact cancer treatment by providing a series of drug development targets which 
reduce metastasis and angiogenesis, crucial processes underlying the progression of 
cancer.  
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Conclusion 
The assumption that epithelial cells at steady-state are well-behaved and 
inflexibly differentiated (rather than primed to divide, grow and move) has so far limited 
our conceptual understanding of carcinogenesis and metastasis. When viewed from the 
perspective that the default state of cells is division and motility, multicellular tissues 
are highly unstable structures. Yet somehow, through complex signaling mechanisms 
such as progesterone receptor mediated induction of the anti-migratory Elf5, a 
differentiated phenotype is maintained. It comes to reason that differentiated cells in 
the body must receive continual cues to maintain that differentiation, as outlined 
previously in the breast, lung, intestine, prostate and salivary gland. An interruption of 
these signals, rather than serendipitous genetic mutations, could lead to the 
unrestricted growth and motility that defines carcinogenesis and metastasis. 
Caught up in the recent pace of technological change for studying DNA and the 
genome, we have become satisfied that a reductionist philosophy and studying the 
nucleus of single cells will sufficiently explain emergent properties of tissues and the 
interactions between cells therein. Our confidence in cracking the genetic code, despite 
the fact that we still do not know the function of over 97% of the genome! (Cavalli-
Sforza 2005) This “non-coding” DNA is almost as likely to be conserved as coding regions 
between species, and such intolerance to mutations over evolutionary time suggests a 
function. (Meisler 2001) Furthermore, it is well known that the DNA sequences of homo 
sapiens and mus musculus are almost identical. Additionally, when one considers 
68 
functional similarity of proteins rather than identical genetic sequences, the amino acid 
sequence for the ribosomal protein L36 is unquestionably homologous and easily 
aligned between homo sapiens, yeast, Escherichia coli, and even the cereal grain rice 
(oryza sativa). (Koonin and Galperin 2003) The answers to the open questions regarding 
cancer cell behavior, which is more thoughtfully understood as the study of normal 
epithelial cells in the absence of differentiation cues, are not in the genome. It is in the 
complex cell-cell interactions that take place within the tissue. Aspects of this signaling 
can be understood by studying the genome and cells in isolation, but the result of cell-
cell interactions within a tissue cannot be predicted from DNA sequences. Only through 
thoughtful study of cell-cell signaling mechanisms, from a variety of in-vivo and ex-vivo 
model systems, will it be possible to reconstruct the complex intercellular interactions 
within actual tissues. As this review hopefully indicates, there exists a wealth of data 
from a variety of model systems, including non-mammalian ones, that could be used to 
develop novel cancer treatments. Tissue-specific cell-cell signaling pathways offer 
specificity light years beyond some of the carpet-bomb chemotherapy treatments still 
being utilized in the clinic. A first step towards this currently unpopular paradigm is 
admitting that our understanding of epithelial cell behavior, the origin of carcinogenesis, 
and the metastatic process, all require revision. 
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navigate the hospital campus (Dec. 2007-March 2010), acted as patient escort 
from outpatient surgery, Emergency Department Family Liaison 
 
Leadership  
Graduate Student Council Representative 
Neuroscience Department, Tufts Sackler School, August 2011-May 2012  
 Co-Editor of the Sackler Insight newsletter, also served on Sackler relays 
committee and social committee 
 Instituted culture change within the Sackler School to further develop graduate 
student community cohesiveness  
 
Certifications:  
AHA Basic Life Support for Healthcare Providers  
 
 
 
 
 
 
 
 
 
 
 
